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ABSTRACT 
 In this thesis, we examined the CID spectra of the closed-shell [A4Wα-Me oxa + H]
+ ions, 
which are completely identical, and indicates sequence scrambling. There are some unique 
fragmentation patterns from this set of ions that have been analyzed in details. 
 The second part of this thesis is the study of the open-shell [A4Wα-Me oxa]
•+ radical cations. 
In this study, we noticed no sequence scrambling, which is a distinctive characteristic. This is 
attributed to the formation of a stable structure with a captodative radical at the N-terminus. 
 We also studied the open-shell [A4Yoxa]
•+ and [A4Moxa]
•+ ions and summarized some 
similarities that are shared between the [A4Goxa]
•+, [A4Yoxa]
•+, and [A4Moxa]
•+ ions. All three 
systems exhibit some isomerization before dissociation; but CID spectra of different sequences are 
non-identical, with different relative abundances. Loss of CO2 is frequently the most dominant 
peak in all three systems. 
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CHAPTER 1: Introduction 
 
1.1 Application of mass spectrometry (MS) in proteomics 
 
Mass spectrometry-based proteomics has become a very powerful technique and a fast-
developing field in molecular biology, following the development of soft ionization methods such 
as electrospray ionization (ESI) and matrix-assisted laser desorption ionization (MALDI) during 
the 1990s.1-8 Modern bottom-up proteomics is able to receive protein samples and generate a list 
of identified proteins within the same day, without the need of additional purification steps. This 
is achieved by a combination of enzymatic digestion, followed by liquid chromatography (LC) 
separation and mass spectrometry analysis.  
 Even though mass spectrometry can detect masses of analytes, detection of a mixture of 
intact proteins can be difficult. Proteins usually undergo post-translational modifications (PTM), 
which makes identification difficult using only the measured m/z values.6 Tandem MS (MS/MS) 
on intact proteins is also difficult, since collision-induced dissociation (CID) is nearly impossible 
due to the large size of proteins. In bottom-up proteomics, proteins are first denatured by adding 
surfactants to increase accessibility of the protein (Figure 1.1). Surfactants being used for 
proteomic need to be compatible with MS analysis. The surfactant either needs to be removable 
by organic solvents, or is acid-labile and becomes decomposed at the end of the digestion 
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protocol.9-12 The denatured protein is then incubated with the added enzyme. Proteases such as 
Lys-C, Arg-C, Asp-N, and Glu-C are commercially available for this purpose, which cleaves 
peptide chains at specific sites.2 Trypsin is one of the most commonly used proteases; it cleaves 
proteins at the carboxyl terminal of a lysine or arginine residue.2,13 The peptide mixture after a 
protein has been digested by trypsin is referred to as tryptic digest peptides, and is ready for further 
separation processing. 
 
 
Figure 1.1 Typical workflow for generating protonated peptide ions in bottom-up proteomics.  
 
Mass spectrometers can detect multiple peptides in one single spectrum, but there would 
be overlapping isobaric peptides which make it too complicated for interpretation if the peptide 
digest mixture is infused into the mass spectrometer all at once, especially when multiple proteins 
are present. The peptide digests are usually first separated using a high-performance liquid 
chromatography (HPLC) before introducing to the mass spectrometer.2 The dissolved peptide 
digest is injected onto a capillary column packed with adsorbent material, the stationary phase, 
which retains hydrophobic analytes. Next, a gradient of two solvents is used to flow through the 
column by applying pressure, which separates the peptides based on their hydrophobicity. The end 
of the HPLC column is connected to an electrospray ion source that ionizes each peptide into the 
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gas phase for them to enter the mass spectrometer. Measuring peptide signals based on the elute 
only will result in a total ion chromatogram (TIC) that represents the elution profiles of the peptide 
digest. There will still be multiple peptides having the same or similar elution profile, but the mass 
analyzer is now able to detect and distinguish the different peptides based on their different m/z 
values. For more accurate identifications, MS/MS analysis is often used to further sequence each 
individual peptide before matching for proteins. For each MS scan, a defined number of peptides, 
usually the three most abundant peptide peaks, will be automatically selected for CID.  
Upon CID of a protonated peptide, the peptide tends to fragment by breaking the amide 
bond. 14-17 This is caused by protonation on an amide nitrogen followed by nucleophilic attack by 
an adjacent carbonyl oxygen on the protonated amide carbon, thereby resulting in the cleavage of 
the amide bond. This results in [bn]
+ ions from the N-terminus and/or [ym + 2H]
+ ions from the C-
terminus (Figure 1.2).18 The y-type ions are believed to be truncated peptides or protonated amino  
 
Figure 1.2 Fragmentation of gas-phase protonated peptides in MS. 
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acids, whereas the structures of [bn]
+ ions are believed to have oxazolone structures at the C-
terminus.15,19-23 These b- and y-type ions are matched with a database to deduce the original peptide 
sequence.2 After the entire HPLC-MS/MS run is completed, and a list of identified peptide is 
obtained, the detected peptides can be matched in the database to identify the proteins that were 
present in the original sample before digestion, along with any modifications.  
 
 
1.2 Collision-induced dissociation (CID) 
 
Since ESI is a soft ionization technique, the selected ions need to be further activated to 
observe for fragmentation and acquire structural information. In modern day instruments, 
collision-induced dissociation is the most commonly used ion activation method, especially for 
quadrupoles and ion traps.24 Ions are activated by provision of a certain amount of kinetic energy 
through electric potentials, followed by inelastic collision with neutral gas molecules (nitrogen, 
helium, or argon), such that kinetic energy of the target ion is converted into internal energy Q in 
the form of molecular vibration. The maximum Q, in which the collision is inelastic, is defined by 
the center-of-mass internal energy of the ion (ECM), and is expressed by the relationship:  
                                                      𝐸𝐶𝑀 = 𝐸𝑙𝑎𝑏 
𝑚𝑁
𝑚𝑁 + 𝑚𝐴𝐵
                                                      (1) 
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where Elab is the kinetic energy applied to the ion, mN is the mass of the neutral gas molecule, mAB 
is the mass of the precursor ion.25-28 This internal energy is then rapidly redistributed throughout 
the molecule in the form vibrations. The final internal energy of the precursor ion after collision 
can be expressed as: 
                                                      𝐸𝐴𝐵
≠ = 𝐸𝐴𝐵 + 𝑄                                                                 (2)           
When EAB
≠ is sufficient to cause dissociation of the precursor ion, the most fragile bonds will break. 
The overall CID process can be described as: 
   𝐴𝐵+ +𝑁 
𝑒𝑛𝑒𝑟𝑔𝑦
→     𝐴𝐵+≠ + 𝑁 →  𝐴+ + 𝐵 + 𝑁                          (3)                    
where A + and B represent the product ion and the neutral loss, respectively, and N represents the 
neutral collision gas molecule. The first step represents the ion activation created by accelerating 
the ion in an electric field, which spans a larger time frame than the second step, which represents 
the dissociation of the ion.  
The extent of fragmentation in a CID spectrum depends on several factors: the amount of 
collisional energy provided; the duration of time over which the ions are being activated; the 
instrumental time scale for ions to travel before they reach the detector; how rapidly the target ion 
redistributes the internal energy; and the efficiency of the CID.24  
The factor that influences fragmentation in CID that is the easiest to understand is the 
collisional energy that the ion acquires in the system. From equation (1) described above, the 
collisional energy, which is the total internal energy of the precursor ion after collision, depends 
on the kinetic energy applied on the ion, the mass of the neutral gas molecule, and the mass of the 
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precursor ion. First, of course, the maximum collisional energy increases with higher Elab, which 
is the kinetic energy that the precursor ion receives as it accelerates before entering the collision 
cell. For example, an ion initially at rest passing through a potential of 10 V would have an Elab of 
10 eV. For ion trap instruments like the QTRAP 2000 and the LIT in the Orbitrap Elite, the ion is 
accelerated with the resonance excitation voltage at a specific frequency for the precursor’s m/z 
value. A greater potential applied on the ion will result in greater collision energy. Equation (1) 
also suggests that the maximum collisional energy increases when the mass of neutral gas molecule 
increases or the mass of precursor ion decreases. The neutral inert gas being used in most 
instruments include N2, He, Ar.
26 Experimental results have shown that heavier gases like argon 
or xenon will give better fragmentation compared to helium.29 CID of large ions with small gas 
molecules should be difficult. However, numerous studies found that CID of large peptides can 
also be very efficient.30 The inert gas that was used in the QTRAP 2000 for radical cation 
experiments is nitrogen (N2) gas, and the inert gas that was used in the Orbitrap Elite for the closed-
shell studies is helium. 
 
 
1.3 Electron-based dissociation (ExD) 
 
Another ion activation method that can be used orthogonally to CID is electron-captured 
dissociation (ECD). In CID, internal energy of the precursor molecule redistributes throughout the 
molecule and converts to vibrational energy before dissociation. As a result, the ion often has a 
sufficient timeframe for cyclization and rearrangement, and the weakest bonds in the precursor 
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molecule will break first.27 For proteins and peptides, the amide bond along the backbone is the 
weakest bond, which results in abundant of b- and y- type ions.31 This characteristic may be useful 
sometimes, but can be problematic for some studies. For instance, post-translational modifications 
(PTM) such as phosphorylation and glycosylation, and non-covalent protein interactions, will be 
cleaved first in CID, leaving no useful information in the mass spectra.  
ECD emerged as a relatively new ion activation method during the past decade. The detail 
mechanisms for ECD-type methods are still under debate, but it is mostly believed to be a non-
ergodic process, meaning that the dissociation process is fast and occurs before redistribution of 
internal energy.32, 33 In ECD, an electron source is produced by a heated dispenser cathode, and 
comes in contact with the trapped precursor ion (Figure 1.3).34 The precursor ion then captures  
 
Figure 1.3 ECD in FT-ICR instruments. A heated dispenser cathode produces electron beam at 
the rear end of the instrument. IRMPD can also be done at the same time by applying a photon 
beam. Figure adapted from Zhurov et. al.34 
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Figure 1.4 Isotopic distributions of (a, b) melittin3+ and (c, d) ubiquitin10+ ions obtained by (a, c) 
ESI and (b, d) ECD. Closed and open circles, theoretically predicted isotopic abundance 
distributions for (M + nH)n+ and (M + nH)(n-1)+, respectively. Figure adapted from Zubarev et. al.35 
 
one electron and becomes a radical species with an odd number of electrons. In the cases of protein 
and peptides, the species will be shown as (M + nH)(n-1)+•, instead of (M + nH)n+ shown in a CID 
spectrum with ESI (Figure 1.4).35 These radical species fragment very differently from those 
demonstrated by CID. Instead of producing b and y ions by cleavage of the amide bond, ECD 
typically breaks the N-Cα bond and results in c and z ions. However, ECD is not a popular method 
since it can only be implemented on FT-ICR instruments.33, 36 This is due to the fact that the 
electromagnetic field of the ICR cell is much better suited for trapping electrons, compared to the 
RF field with low mass cut-off in a quadrupole type ion trap. 
To overcome the limitation of ECD and use the technique more broadly, Syka et al. 
introduced electron transfer dissociation (ETD) in 2004.36 In ETD, electrons are not dispensed 
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directly and captured by the precursor ion. Instead, a secondary molecule is ionized into an anion 
through chemical ionization and acts as an electron donor, and then transfers the electron to the 
precursor ion. One very crucial step in this technique is to choose an efficient reagent anion that 
easily transfers an electron to the cation precursor, since this step often competes with proton 
transfer from the cation.37 Several polyaromatic compounds have been experimented for this 
purpose, many of them shown electron transfer without dissociation.38, 39 To date, fluoranthene is 
the most preferred reagent, although its efficiency in electron transfer is only 40%.37 One of the 
most popular commercial instrument that employs ETD is the Orbitrap. In the Orbitrap Elite.40 
Fluoranthene anion is produced through negative chemical ionization in the ETD module at the 
back end of the instrument. The ETD process can be described in the following steps: 
 
N2 + e
-
fast → N2•+ + e-slow + e-fast 
fluoranthene + e-slow → fluoranthene•- 
[M + nH]n+ + fluoranthene•- → [M + nH]•(n-1)+ + fluoranthene 
 
Nitrogen gas is used as a carrier gas that sweeps fluoranthene into the gas phase. As 
negative chemical ionization, hot electrons (70 eV) are emitted from a filament, and knock 
electrons off from the nitrogen gas molecules. These electrons are captured by the fluoranthene 
molecules to create anions, which are then ready to transfer to the ion trap through quadrupole ion 
guides. 
There are also variations in ECD, one of them is electron-induced dissociation (EID), for 
singly charged ions. Typical ECD techniques use low energy electrons ( < 0.2 eV). When a singly 
charged ion [M + H]+ is exposed to high energy electrons ( > 10 eV), which exceeds its first 
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ionization energy, it can be further ionized to become [M + H]•2+ , and this is called tandem 
ionization.41-43 The [M + H]•2+ will then re-capture a low energy electron. The end result will be a 
singly charged ion that has the same m/z and same number of electron with the original species, 
but is electronically excited. The process can be described as below: 
 
[M + H]+ + e-fast  →  [M + H]•2+ + e-slow + e-fast 
[M + H]•2+ + e-slow  →  [M + H]+≠ 
 
Since the electron-capture process is exothermic and the ion is electronically excited, it 
will undergo fragmentation. The fragmentation pattern from EID has similarities with PD, since 
the ions are both electronically excited.43 EID is usually used on small singly charged molecules 
that are difficult to acquire multiple charge, such as small peptides, polyketides, and small 
pharmaceutical molecules.42,44,45  
For studies on anions, such as acidic peptides, several variations of ECD for negative mode 
have been published.33 These include electron detachment dissociation (EDD), negative electron 
transfer dissociation (NETD), and negative ion ECD (niECD). EDD has similarities with EID, 
which involves tandem ionization of a multi-deprotonated anion by collision with a high energy 
electron ( > 10 eV).33, 46 
[M – nH]n- + e-fast  →  [M – nH]•(n-1)- + e-slow + e-fast 
 
The electron detachment process is exothermic, and the resulting multi-deprotonated 
radical anion will fragment primary by the cleavage of Cα−C bond, which produces a- and x-type 
ions.46, 47  
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NETD is another negative mode technique that is analogous to ETD. Instead of producing 
a radical anion with fluoranthene that donates an electron, NETD employs EI to produce radical 
cation fluoranthene, by removing the carrier gas supply and maintain sufficient vapor pressure of 
fluoranthene by increasing the temperature.47  
 
fluoranthene + e-fast → fluoranthene•+ 
[M - nH]n- + fluoranthene•+ → [M - nH]•(n+1)- + fluoranthene 
 
For singly charged anions, Yoo et al. introduced negative ion ECD (niECD) in 2011.48 
They have discovered that, although it is difficult for gaseous anions to capture electrons due to 
repulsion, it is possible for small anions ([M – nH]n-, n ≥ 1) to capture an electron within a narrow 
energy range (~3.5 eV – 6.5 eV). Fragmentation through niECD follows a similar mechanism with 
that through ECD and produces primary c- and z-type ions. This technique is useful for studies of 
PTMs in small acidic peptides, which is difficult to acquire multiple charge required by EDD and 
NETD. 
Electron-based dissociation techniques have rapidly evolved during the past decade, from 
ECD that is limited to only FT-ICR instruments, to the more widely-adapted ETD. Numbers of 
variations for negative mode and singly charged ions have also been developed, which make this 
type of ion activation method more feasible for different types of analytes. Electron-based 
dissociation has shown prominent application in top-down proteomics, where CID is inefficient 
for fragmentation of intact proteins, and at the same time it is easy for proteins to acquire multiple 
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charge. ECD or ETD is also used orthogonally with CID in proteomics since they produce different 
fragmentation patterns, which helps to increase sequence coverage significantly, and retains PTM 
information at the same time. 
 
 
1.4 Hydrogen-deficient radical cation formation 
 
Radical peptide ions that are generated using ExD techniques have high energy, which 
gives them the non-ergodic property and results in quick dissociation.33 However, to study the gas 
phase chemistry of peptide radical cation, we need to record the onset of each fragmentation 
pathway starting from low energies. The hydrogen-deficient radical cations, generated from 
oxidative dissociation inside the mass spectrometer, are more desirable for the purpose of 
fundamental study. One of the most widely used methods for generating such species is by the use 
of copper (II) ion (Cu(II)).50 This technique was first discovered by Chu et. al. by using 
diethylenetriamine (dien) as an auxiliary ligand to form a dipositive complex with Cu(II) and 
oligopeptides that contain both tyrosine and a basic residue (arginine, lysine, or histidine). The 
proposed structure for the complex consists of a dien molecule coordinating the five-coordinate 
Cu(II) atom with the three amines, and the peptide coordinating the other two with the N-terminal 
amine and the phenolic oxygen. CID of this complex yielded the reduced [Cu(I)(dien)]+ and the 
desired [M]•+ radical peptide (Figure 1.5).  
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Figure 1.5 CID spectra of the [Cu(II)(dien)YGGFLR]•2+ complex with 63Cu (upper) and 65Cu 
(lower). Figure adapted from Chu et. al.50 
 
In addition to dien, there are numerous auxiliary ligands that have been employed for this 
application, such as 2,2,’:6’,2”-terpyridine (terpy) and 12-crown-4.50-52 Dien, which was initially 
used, have mobile protons at the amine groups, which may facilitates proton transfer to the radical 
cation being produced and generates a protonated peptide. Since we want to avoid this competitive 
pathway when generating peptide radical cations, ligands with tertiary amines, such as terpy, had 
M = YGGFLR 
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became a better choice. Crown ether is also a popular group of ligands for binding metal ions. It 
acts as a planar ligand, as opposed to terpy. The size and the type of ligand needed for generating 
peptide radical cations depend on the size and side chains of the peptide, and also the metal being 
used. Throughout the study in this thesis, we selected 18-crown-6 as the auxiliary ligand. To 
generate the desired hydrogen-deficient radical cation from our synthesized peptides, the peptide 
sample was mixed with copper perchlorate hexahydrate (Cu(ClO4)2•6H2O) and 18-crown-6 in 
approximately 1:1:1 ratio in 50:50 (v/v) water : methanol. The prepared solution was continuously 
infused into the mass spectrometer as the ESI source, and the dipositive complex [Cu(II)+L+M]•2+ 
(L = 12-crown-6, M = target peptide) was selected as the precursor ion for CID. The complex 
dissociates into [Cu(I)+L]+ (m/z 327) and [M]•+, and the latter was selected for further analysis. 
The process is illustrated as follows: 
                 [Cu(II)+(18-crown-6)+M]•2+ 
𝐶𝐼𝐷
→   [M]•+ + [Cu(I)+(18-crown-6)]+ 
 
 
1.5 Sequence scrambling in [b5]+ and [b5 – H]•+ ions 
 
The commonly used CID is a relatively slow ion activation process and is ergodic. This 
means that the selected and activated precursor ion has sufficient time to redistribute the internal 
energy throughout the molecule, and may undergo rearrangements, before dissociation.53,54 Recent 
studies have shown that for the closed-shell [bn]
+ ions of longer peptides, the N-terminal amine 
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can attack the carbonyl carbon in the oxazolone ring to form a cyclic polypeptide (Figure 
1.6).15,55,56 The cyclic structure of [b5]
+ ions have been verified by Erlekam et al., with a protonated 
amide oxygen.57 This common cyclic polypeptide will reopen and fragment at preferred sites. 
Consequently, the original sequence information of the peptide ion can be lost, and we call this 
sequence scrambling. It has also been known that sequence scrambling is significant for [bn]
+ ions 
only when n > 3.58 [b5]
+ ions that contain a tyrosine or tryptophan residue along with four alanine 
residues have been studied previously, and both exhibited sequence scrambling.51,59 There was a 
marked preference for loss of the hetero-residue, with both sets of [b5]
+ ions losing approximately  
 
Figure 1.6 Sequence scrambling of [b5]
+ ion of [YAGFLoxa +H]
+ through macrocyclization. The 
subscript “oxa” denotes the oxazolone structure at the C-terminus (R1=CH3, R2=H, R3=C7H7, 
R4=C4H9, R5=C7H7O). Figure adapted from Harrison et. al.
56 
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equal amounts of the imines derived from alanine and tyrosine or tryptophan residues. Since open-
shell radical cations often show richer fragmentation chemistries compared to the closed-shell ions, 
we are interested in studying the [b5 – H]•+ radical cation, which is analogous to the [b5]+ ion from 
a protonated peptide. 
Our previous studies on the [b5 – H]•+ ions that contain four alanine residues and one 
tryptophan residue at different positions showed complete sequence scrambling of the ion.59 These 
[b5 – H]•+ ions form a common macrocyclic structure, followed by ring-opening into the sequence 
[AAAAWoxa]
•+, with the radical located at the α-carbon of the tryptophan (Figure 1.7). This α-
radical is adjacent to the nitrogen atom in the oxazolone ring, where the proton is often located 
and this facilitates proton migration onto the backbone, thereby triggering the cleavage of peptide 
bonds.   
 
Figure 1.7 Sequence scrambling and dissociation of [b5 – H]•+ derived from [A4Woxa]•+.59 
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In order to continue our investigation of sequence scrambling in b-type ions, we decided 
to examine [b5 – H]•+ ions again with four alanine residues, but with one α-methyltryptophan 
residue. The formation of the α-radical is no longer possible and having a methyl group on the - 
carbon of the tryptophan makes the α-carbon more sterically hindered; consequently the other three 
bonds connected to this α-carbon are lengthened and therefore potentially more fragile. The key 
structural feature in the isomer of the [A4Woxa]
•+ ions that dissociated was the location of the radical 
on the α-carbon of the tryptophan residue in the oxazolone ring.  Here we ask the questions does 
macrocyclization still occur and what dissociation mechanism is followed if formation of the α-
radical is prevented by the presence of a methyl group on the α-carbon of the tryptophan?  Based 
on our calculations on the isomers of [A4Woxa]
•+, plausible structures for the [A4Wα-Me oxa]
•+ ions 
may have (i) a captodative structure with the radical on the α-carbon of the N-terminal residue and 
the proton on the oxygen of the first peptide bond (Figure 1.8 ion I), (ii) a β- radical on the side 
chain of the α-methyltryptophan residue and the proton on the peptide backbone (Figure 1.8 ion 
II), and (iii) a structure in which both the charge and the radical are located on the aromatic system 
of the indole ring (Figure 1.8 ion III). Macrocyclization is facilitated by having the charge on the 
oxazolone ring, making it susceptible to nucleophilic attack; similarly, the terminal amino should 
be freely available.  These structural requirements suggest that both the captodative structure and 
the π-radical are unlikely to macrocyclize and sequence scrambling would probably not be 
observed from these structures.  
 We are also interested in the difference in fragmentation of the protonated peptides, peptide 
radical cations, and the [b5]
+ ions when an α-methyl group is introduced on the tryptophan residue.  
Hexapeptides were synthesized to produce a series of [b5]
+ ions that contain four alanine residues 
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Figure 1.8 Plausible structures for the [A4Wα-Me oxa]
•+ ions. 
 
and one -methyltryptophan residue, with the latter at all different positions except for the first. 
Results and detailed comparisons will be discussed in this thesis.  
 Another research direction is to study the [b5 – H]•+ in hexapeptides that contain a 
methionine residue, as well as hexapeptides that contain a tyrosine residue. To date, many studies 
have been done on peptide radical cations with aromatic side chains, such as tryptophan, tyrosine, 
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histidine, and phenylalanine.50,59-61 These ions are particularly stable because of the ability of the 
aromatic systems to stabilize the charge and the radical, making it easy to produce M•+. There are 
also studies on radical peptide radicals with cysteine, by homolytic cleavage of the S-NO bond in 
the nitrosylated peptide.62-65 Also, there are studies on making radical cations with methionine 
amino acid and dipeptides using Cu2+/acetonitrile (ACN) complexes.66,67 Our goal is to continue 
to explore the open-shell [b5 – H]•+ ion from systems containing methionine and tyrosine, and 
compare with those derived from the systems that have been known. 
 The research goal of this thesis is to understand the sequence scrambling properties and 
dissociation patterns of both the closed-shell [b5]
+ ions and the open-shell [b5 – H]•+ ions. We 
aimed to understand the behavior of these b-type ions by comparison between simple systems that 
contain four alanine residues and one hetero-residue at different positions. We were interested in 
finding out whether having different hetero-residues in the ion would change the scrambling 
behavior, especially for the open-shell [b5 – H]•+ ions, as well as the effect of simple modifications 
such as having an α-methyl group on the hetero-residue. This information in gas phase chemistry 
will be needed, in order to build a stronger foundation for proteomics by improving efficiency and 
accuracy of the database search algorithm. 
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CHAPTER 2: Experimental 
Techniques 
 
 
2.1 Electrospray ionization  
 
In the past century, mass spectrometry has rapidly developed. The early mass 
spectrometers relied on an electron impact (EI) ion source, which causes fragmentation of 
molecules at the front end of the instrument.68,69 To retain the structure of the analyte in the gas 
phase inside the mass spectrometer, soft ionization techniques, such as electrospray ionization 
(ESI), were developed and gained popularity.2 ESI-MS has rapidly emerged into the proteomics 
field, as it can be used for structural analysis of a wide range of thermally labile biomolecules, 
including proteins, peptides, and drugs. However, while the intact structure is often retained using 
soft ionization techniques, further ion activation methods, such as collision-induced dissociation, 
are needed to fragment the ion for more detailed structure elucidations. 
An ESI source can be very simple. The principle behind ESI is to deliver a flow of solution 
through a capillary with elevated voltage, relative to the orifice on the opposite side where ions 
enter the mass spectrometer.2,70 This will form charged droplets from the tip of the ESI capillary, 
or the ESI emitter. These charged droplets undergo solvent evaporation and electrostatic repulsion 
and reduce in size, which will increase in charge density, and ultimately result in formation of the 
charged gas-phase ions (Figure 2.1).71 This process happens in an atmospheric region before the 
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ions enter the orifice. An annular flow of inert gas, also called the sheath gas, is often used to flow 
in the same direction outside of the inner capillary, to assist in forming the small droplets.  
For study on the closed-shell [b5]
+ ions from peptides containing an α-methyltryptophan 
residue, all experiments were conducted on an Orbitrap Elite™ Hybrid Ion Trap-Orbitrap Mass 
Spectrometer (Thermo Fisher Scientific) in positive mode, with a heated electrospray ionization 
(H-ESI) source. In H-ESI, sample solution passes through a heated metal needle.71 At the ESI 
 
Figure 2.1 Process of ion formation from an ESI source. Figure adapted from HESI-II probe user 
guide.71 
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Figure 2.2 Introduction of sheath gas and auxiliary gas into H-ESI used on the Orbitrap. Figure 
adapted from HESI-II probe user guide.71 
Sheath gas inlet 
Auxiliary gas inlet 
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nozzle, the inner sample needle protrudes approximately 1.5 mm from the tip of an outer ESI 
needle (Figure 2.2). As the sample passes through the ESI nozzle, it receives an elevated voltage, 
which is typically set at 3.5 kV, and is sprayed into small droplets with the aid of a flow of nitrogen 
sheath gas from the outer ESI needle. There is an optional flow of nitrogen auxiliary gas (aux gas),  
which is also coaxial and is passed through a vaporizer on the outer ring of the ESI needle.  The 
aux gas is heated in the vaporizer and is able to assist in solvent evaporation of the droplets. 
Throughout our study, the sheath gas was set at 3.5 psi and aux gas was turned off. The sample 
flow rate was 5 µL/min. 
 For study of the [b5 - H]
•+ radical cations from peptides that contain α-methyltryptophan or 
methionine, all experiments were conducted on a Sciex QTRAP 2000 prototype, with an ESI probe 
that consists of a simple capillary connected to an emitter tip. An ESI voltage of 3-4 kV is typically 
used and is applied near the tip of the emitter. Sample flow rate was at 3-5 µL/min.  
 
 
2.2 Mass analyzers 
2.2.1 Quadrupole mass filters and linear ion trap 
 
Quadrupole mass analyzers are very common in modern commercial MS. A single 
quadrupole consists of four parallel electrodes. Each pair of opposite electrodes is separately 
applied with the DC voltage U and a radiofrequency (RF) voltage V with frequency ω (Figure 
2.3).26,72 When a positive ion enters the quadrupole in the z-direction, it will oscillate in both x- 
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and y- directions because of the alternating attraction and repulsion exerted by the electrodes with 
RF voltages. At a given U, V, and ω, only the ions with a specific mass to charge ratio (m/z) forms 
a stable trajectory within the quadrupole and pass through the exit lens to be detected. A 
quadrupole acts as a mass filter, which filters ions with one specific range of m/z value at a time. 
Keeping a specific U/V ratio and increasing the magnitude allows ions with increasing m/z value 
to pass through the quadrupole; while adjusting the U/V ratio will change the window size of the 
m/z range, 
 
Figure 2.3  Schematic diagram of a quadrupole. Each pair of opposite electrodes consists of a 
DC voltage U and an alternating RF voltage V. Figure adapted from Gross.26 
 
which changes the resolution and sensitivity in the mass spectrum. A final mass spectrum is 
produced by specifying an U/V ratio and detecting ions while increasing voltage magnitudes.  
 For applications of transmitting ions, applying only the RF voltage will create a wide band 
pass for essentially all ions.26,73 Applying an opposite potential at both end of and RF-only 
quadrupole allows ion storage, which becomes a linear quadrupole ion trap. For the QTRAP 2000 
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(Sciex) used for all of the radical cation studies in this thesis, it consists of three main quadrupoles. 
The first quadrupole (Q1) selects the first precursor ion, which is always the [Cu(II)+L+peptide]•+ 
complex in all of the radical cation studies in this thesis. For this quadrupole, the resolution is set 
at a low resolution to allow bigger windows, in order to allow higher signals for later MSn 
experiments. The complex selected in Q1 passes through the quadrupole and enters Q2 for CID. 
Q3 is a linear ion trap. Fragment ions from Q2 enter Q3, which initially traps the ion by first 
applying a DC voltage at the exit lens to prevent ions from exiting, then applies another DC voltage 
at the entrance lens after a specified fill time of 2 seconds. The second precursor is selected in Q3 
by applying auxiliary RF for all other m/z, which gives other ions enough energies to overcome 
the exit potential and leave the quadrupole. Then, another auxiliary RF is applied in Q3 to activate 
the second precursor ion and perform CID within Q3. In addition, we modified the method table 
for Q3, to perform MSn experiments by instructing the instrument to repeat the selection and 
activation stage before scanning.  
 
2.2.2 Dual-pressure linear ion trap 
 
Inside the Orbitrap Elite (Thermo Fisher Scientific) used for the closed-shell [b5]
+ study is 
a dual-pressure linear ion trap system. It consists of two separate linear ion traps: the first trap is 
the high-pressure cell for CID, followed by a low-pressure cell for ion scanning (Figure 2.4).40 
Each of the linear ion trap consists of four hyperbolic rods, with each rod divided into three sections 
(Figure 2.5).74 Each section of each trap has a separate DC trapping voltage during axial trapping. 
The high-pressure cell is supplied with helium gas for CID. Upon axial trapping of ions in the 
high-pressure cell, an ion isolation waveform voltage is applied to a pair of exit rods with a slot on  
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Figure 2.4 Schematic diagram of the Orbitrap Elite. Figure adapted from Orbitrap Elite 
hardware manual.40 
 
each of them. This AC voltage works with the main RF voltage and eject all ions except the 
selected precursor ion. Next, a resonance excitation AC voltage is applied on the exit rods to 
resonate with the precursor ion. The precursor ions gain kinetic energy and collide with the helium 
gas molecules to cause fragmentations. After CID, all the fragment ions are transmitted to the low-
pressure cell for scan-out. During scan-out, the main RF voltage ramps from low to high, and a 
resonance ejection AC voltage is applied on the exit rods simultaneously. This causes ions from 
low to high m/z ratio to become unstable and eject through the slots on the two exit rods (Figure 
2.6). Outside of each of the two exit rods is an ion detector system, which consists of an electron 
multiplier and a conversion dynode. 
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Figure 2.5 Components of a linear ion trap in the Velos Pro portion of the Orbitrap Elite. Figure 
adapted from LTQ series hardware manual.74 
 
 
Figure 2.6 Diagram for the scan-out process in the low-pressure cell. Figure adapted from LTQ 
series hardware manual.74 
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2.3 Chemicals 
2.3.1 Reagents 
 
Fmoc-α-Me-Trp(boc)-OH was purchased from ChemPep (Wellington, FL). For labeled 
peptides, L-Ala-3,3,3-d3-N-Fmoc and L-Ala-
15N-N-Fmoc were purchased from CDN Isotopes 
(Québec, QC). Other Fmoc-protected amino acids and synthesis reagents were purchased from 
Advance ChemTech (Louisville, KY). 
 
2.3.2 18O-labeling of amino acids 
 
In order to study the site specificity of fragments and losses that contain oxygen atoms, 
such as CO or CO2, 
18O-labeled peptides were synthesized by exchanging the oxygen atom of the 
fmoc-protected amino acid with H2O
18 prior to solid-phase peptide synthesis (SPPS). This was 
achieved by acid-catalyzed 18O-exchange according to the literature.75 Detailed procedures were 
carried out as follows: 
1. An oven-dried Schlenk flask was mounted and connected with a nitrogen gas supply 
on the side-arm. A magnetic stirrer was placed inside the flask. 
2. The stopcock was opened and the flask was supplied with nitrogen gas. An inert gas 
flow was created from the side arm to the neck of the flask, to prevent air and moisture 
from entering. 
3. Approximately 2 mL of anhydrous 1,4-dioxane was transfer using a needle syringe, 
from a septum-sealed bottle to the flask. 
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4. 1- 2 mmol of the fmoc-protected amino acid was added into the flask. 
5. 1 mL of H218O (50 mmol) was transferred into the flask using a needle syringe. 
6. 18 µL of acetylchloride (0.25 mmol) was transferred into the flask using a microsyringe. 
7. The Schlenk flask was connected to a condenser, with a polytetrafluoroethylene (PTFE, 
or Teflon) sleeve for sealing the neck. The top of the condenser was connected to a 
nitrogen supply, which is also connected to an opened oil bubbler to release excess 
pressure. The stopcock and nitrogen gas supply on the side-arm of the Schlenk flask 
was then closed.  
8. The round bottom of the Schlenk flask was immersed in an oil bath at 100 °C with 
magnetic stirring and the condenser on. 
9. The exchange reaction was left to react overnight. 
10. The oil bath was removed and the reaction mixture was allowed to cool to room 
temperature. 
11. Open the stopcock and the nitrogen supply on the side-arm. Then, the condenser was 
removed from the Schlenk flask. The flask was then connected to a glass bridge, which 
is connected with a 50 mL round bottom flask. The stopcock and nitrogen supply on 
the side-arm were closed immediately.  
12. The 18O-exchanged fmoc-protected amino acid was freeze-dried. The reaction mixture 
in the Schlenk flask was froze by immersing in liquid nitrogen. Then, a vacuum line 
was connected to the side-arm of the Schlenk flask and created a low pressure system. 
The vacuum line was closed by the stopcock after around 1 minute. 
 30 
 
13. Liquid nitrogen was then removed from the Schlenk flask and applied on the round 
bottom flask. As the frozen mixture evaporates in the Schlenk flask under reduced 
pressure, it traveled through the bridge and condensed in the round bottom flask.  
14. The dried labeled fmoc-protected amino acid in the Schlenk flask was stored in -18 °C 
before use for SPPS. 
 
 
2.3.3 Solid-phase peptide synthesis  
 
Peptides used in all experiments in this thesis were synthesized by solid-phase peptide 
synthesis (SPPS) according to the commonly accepted procedures from the literature.76 Detailed 
procedures for this technique are outlined as below: 
 
1. Wang resin with a bound fmoc-protected amino acid was first soaked in dichloromethane 
(DCM) and bubbled with nitrogen gas inside a reaction vessel for around 15 minutes. This 
amino acid will be the C-terminal residue of the final peptide. Then the DCM was removed 
by filtering out the resin. 
2. 20% (v/v) piperidine in dimethylformamide (DMF) was added into the reaction vessel, 
with about three bed volumes. The resin was left to react with the piperidine under nitrogen 
gas for 20 minutes. The fmoc protecting group at the N-terminus of the amino acid is now 
removed as illustrated in Scheme 2.1. 
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Scheme 2.1 Mechanism for cleavage of fmoc protecting group by piperidine during SPPS. 
 
3. The resin was filtered and washed with DMF three times, and then washed with DCM three 
times. 
4. The next fmoc-protected amino acid was added into the reaction vessel, with 3 mole-
equivalence of the Wang resin added. For fmoc-α-methyltryptophan-OH, 1.5 mole-
equivalence was added to save cost. 500 µL of diisopropylcarbodiimide (DIC) and 500 µL 
of 1-hydroxybenzotriazole (HOBt) was added to activate the carboxylic group of the added 
fmoc amino acid, by turning it into an activated ester which reacts readily with amines at 
room temperature (Scheme 2.2). Approximately three bed volumes of DMF was added to 
ensure an even mixture of the reagents. The mixture was left to react with the resin in the 
reaction vessel for 2 hours. 
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Scheme 2.2 Activation of carboxylic group into an active ester, and formation of the amide bond. 
 
5. The resin was filtered and washed with DMF three times, then washed with DCM three 
times. 
6. Step 2-5 was repeated multiple times to incorporate amino acid residues from the C-
terminus to the N-terminus. 
7. After the N-terminal residue of the desired peptide had been incorporated, repeat step 2 to 
remove the fmoc protecting group from the N-terminus. 
8. A cleaving solution was prepared with trifluoroacetic acid (TFA), DCM, triisopropylsilane 
(TIS), and H2O, in a ratio of 14:4:1:1 (v/v). Around two bed volumes of the cleaving 
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solution was added into the vessel for cleavage of the peptide from the Wang resin, as well 
as any protecting group for the side chain, such as the boc protecting group on the α-
methyltryptophan side chain. The mixture was left to react for 2 hours under nitrogen. 
9. The resin was filtered and the filtrate was collected. The resin was washed 3-4 times with 
small volumes of DCM, and the filtrates were pooled together in a 50 mL round bottom 
flask. 
10. The pooled solution containing the synthesized peptide was left to evaporate under reduced 
pressure and resulted into a small volume of oil or solid. Approximately 10 mL of cold 
anhydrous diethyl ether was added into the flask. The flask was sonicated briefly and the 
solution became cloudy. 
11. The solution was left in a freezer (-16 oC) for 15 minutes for the white solids to precipitate. 
The solution was carefully removed from the precipitate. The white precipitate, which is 
the synthesized peptide in solid form, was left to dry and then stored in the freezer (-16 oC) 
until needed for experiments. 
 
2.3.4 Sample preparation 
 
After the peptides were synthesized and dried into solid form, they were stored at -18 °C 
without further purifications. Prior to experiment, the synthesized peptides were taken out from 
the freezer and dissolved in 50/50 water/methanol, followed by proper dilution.  
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CHAPTER 3: Fragmentation of 
α-methyltryptophan-containing 
Hexapeptides and Their [b5]+ 
Ions 
 
 
 
3.1 Results and discussions 
3.1.1 Fragmentation of the protonated hexapeptides 
 
 CID spectra of the protonated peptides [M + H]+ of -methyltryptophan-containing 
hexapeptides are summarized and compared with those of their native tryptophan-containing 
analogs (Figure 3.1). In all spectra, the [b5]
+ ion is the most dominant product ion, regardless of  
whether or not there is a methyl group at the -carbon of the tryptophan, and is independent of 
where the tryptophan or -methyltryptophan residue is located in the sequence. Other 
fragmentations include (i) a further loss of CO from the [b5]
+ ion to produce the [a5]
+ ion and (ii) 
loss of a dipeptide from the C-terminus giving the [b4]
+ ion, the second most abundant ion in all 
the spectra (with the exception of [AAAAWα-MeG + H]
+, where there is essentially only one 
product, the [b5]
+ ion). There are some small simplifications in the spectra that appear to be a 
function of replacing the α-hydrogen of tryptophan by a methyl group. Loss of water is a minor 
 35 
 
  
Figure 3.1 CID spectra of the protonated hexapeptides, with the hetero-residue at different 
positions. (A) – (D): CID of tryptophan-containing hexapeptides. (E) – (F): CID spectra of α-
methyltryptophan-containing hexapeptides. 
 
channel that is less prevalent for peptides containing α-methyltryptophan. Also [yn + 2H]+ ions in 
which the tryptophan residue is at the N-terminus are observed for the tryptophan-containing ions; 
these are the products of cleaving the amide bond at the N-terminal of the tryptophan residue.  In 
summary, having a methyl group at the -carbon of the tryptophan residue results in only small 
changes in the dissociation pathways of these protonated peptides.   
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3.1.2 Fragmentation of the [b5]+ ions 
 
 The [b5]
+ ions observed in the CID spectra of the protonated hexapeptides were isolated 
and subjected to further fragmentations (Figure 3.2). The dissociations of [b5]
+ ions which are 
derived from -methyltryptophan-containing hexapeptides can produce two different [bn]+ ions (n 
= 2-4), one containing the -methyltryptophan residue which we will denote as [bn]+, and the other, 
without this residue, is labeled as [bn′]+. As observed for the [b5]+ ions from peptides derived from 
tryptophan-containing hexapeptides (Figure 3.3),59 the [b5]
+ ions in Figure 3.2 also showed very 
similar spectra, regardless of the original sequence. This indicates that the -methyltryptophan-
containing ions also cyclize to form a common intermediate prior to fragmentation.  
In order to differentiate between the alanine residues, we label their positions relative to 
the α-methyltryptophan residue.  As there is a greater loss of the α-methyltryptophan residue (m/z 
285) than the alanine residue (m/z 414) from [b5]
+ and, assuming that this occurs from an oxazolone 
ring at the C-terminus, then the structure [AAAAW-Me oxa
 + H]+ appears to be a dominant one in 
the fragmentation process and we have used this sequence as the basis for labeling. The following 
reference to each alanine residue relative to the hetero-residue will be used throughout this thesis. 
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Figure 3.2 CID spectra of [b5]
+ ions derived from α-methyltryptophan-containing hexapeptides, 
with the α-methyltryptophan residue at different positions. 
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Figure 3.3 CID spectra of the [b5]
+ ions derived from tryptophan-containing hexapeptides.59 
 
The [b5]
+ ions derived from both classes of protonated hexapeptides show the same 
progression of [b4]
+, [b4′]+, [b3]+and [b3′]+ ions, but the relative abundances are quite different in 
the two series. Also, there are additional product ions in the CID spectra of the -
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methyltryptophan-containing ions. The differences and some of the unusual features observed for 
the -methyltryptophan-containing [b5]+ are summarized below: 
i) loss of CO2 is observed and is the most abundant peak in all the spectra collected although 
it is not the lowest-energy fragmentation channel (vide infra). Such a loss is frequently 
observed in the CID spectra of open-shell radical cations,60,52 but is unusual in the spectra of 
closed-shell [b5]
+ ions derived from protonated peptides. 
ii) a loss of 117 Da is observed. The high-resolution CID spectrum suggests that this loss does 
not correspond to the indole ring from the -methyltryptophan side chain (C8H7N). Instead, 
the neutral being lost corresponds to (C4H7NO3, Figure 3.4). 
iii) the abundance of [b4′]+ (m/z 285) is large and approximately twice that of the [b4]+ ion (m/z 
414).  This suggests that after macrocyclization and reopening, the [b5]
+ ion with the -
methyltryptophan residue at the C-terminus is the most fragile and is the key intermediate 
leading to most of the fragmentations. By comparison, in the fragmentations of [b5]
+ ions 
derived from [AAAAWoxa]
+ (Figure 3.3), the abundances of [b4′]+ and [b4]+  ions are 
approximately the same. 
iv) the [b3]+ ion (m/z 343) resulting from the loss of two alanine residues (142 Da) is more 
abundant than the [b4]
+ ion, the product of the loss of one alanine residue (71 Da). Also, the 
abundance of the [b2]
+ (m/z 272) is comparable to that of the [b4]
+ ion.  By comparison in the 
dissociation of the [b5]
+ ions with four alanine and one tryptophan residue, loss of one alanine 
residue is more abundant than the loss of two, and there is essentially no loss of additional 
alanine residues. 
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Figure 3.4 CID spectrum of [AAWα-MeAAoxa + H] 
+ in high-resolution FTMS (240,000 FWHM). 
All observed mass values are within 1 ppm error from the theoretical mass values of the predicted 
structures. The observed mass of 368.2081 Da represents the ion C20H26O2N5 (0.27 ppm), a loss 
of C4H7NO3; instead of the structure C16H26O5N5 (41.3 ppm), a loss of C8H7N (indole). 
 
v) There is a high abundance of the ‘internal’ [a1]+ (m/z 173), the imine derived from α-
methyltryptophan.   
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3.1.3 Structural information provided by isotopic labeling 
 
The CID spectra of the [b5]
+ ions of [AAAWα-MeAoxa + H]
+ where one of the Ala residues 
has a CD3 side chain (A
D3) (Figure 3.5) and an 18O-labeled amide oxygen (A18O) (Figure 3.6) are 
summarized, While Figure 3.7 shows a different isomer [AWα-MeAAAoxa + H]
+, with one Ala 
residue containing CD3 and in another one having 
15N-labeled amide nitrogen (A15N). These 
strategically located substitutions have enabled us to make conclusions about the structures of the 
ions undergoing cleavage. 
 
Ion at m/z 414, loss of an alanine residue (71 Da).  
Figure 3.5 and Figure 3.6 show that in the loss of a single alanine residue from the [b5]
+ 
ion, Ai is lost more easily than Aii and that Aiii is not lost (Figure 3.5 C). Loss of residue Aiv is 
also possible, as exhibited by Figures 3.6 C and Figure 3.7 B.  From these data we estimate that 
approximately 40% of the alanine loss comes from each of positions Ai and Aiv with the remaining 
20% from position Aii.  
 
Ion at m/z 343, loss of two alanine residues (142 Da).  
As noted earlier, the product of the loss of two alanine residues is more abundant than the 
loss of only one alanine.  The spectra in Figure 3.5 B show that when the CD3 is at position A
ii 
only labeled AD3Aoxa is lost; furthermore, when the CD3 is at each of the adjacent positions (A
i and  
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Figure 3.5 CID spectra of isotopomers of ion [AAAWα-MeAoxa + H]
+ (A),  with (B) – (D) having 
a CD3 label at the first, second, or fifth residue respectively. 
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Figure 3.6 CID spectra of isotopomers of ion [AAAWα-MeAoxa + H]
+ (A),  with (B) and (C) having 
an 18O label at the fifth and third residue respectively. 
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Figure 3.7 CID spectra of the ion [AWα-MeAAAoxa + H]
+ with both 15N label and CD3 labels at 
different residues. 
 
Aiii), approximately half the label is lost.  Clearly, the loss of two alanine residues is either from 
residues Ai and Aii or residues Aii and Aiii. The spectra in Figure 3.7 supports this analysis and 
suggests that there is slightly more loss of residue Ai than Aiii. 
 
 
 45 
 
Ion at m/z 272, loss of three alanine residues (213 Da).  
From Figure 3.5 B, C and D, there is no product ion at m/z 275, indicating that the CD3-
labeled alanine is always lost.  This means that the product is the [b2]
+ ion consisting of residue Aiv 
and the -methyltryptophan residue, presumably [AWα-Me oxa + H]+. This is consistent with the 
result of 15N and CD3 labeled peptide in Figure 3.7 that the ions at m/z 272 and 275 correspond to 
the loss of three alanine residues at positions Ai, Aii, and Aiii from the [AWAAAoxa + H]
+ ion. 
Again, product ions at m/z 272 and 274 from the 18O labeled [b5]
+ ions of [AAAWα-MeA
18O + H]oxa
+ 
and [AAA18OWα-MeAoxa + H]
+, respectively support this analysis.  Note that in the losses of both 
two and three alanine residues, the amide bond between A−W-Me is never broken. 
 
Ion at m/z 368, loss of (C4H5NO2 + H2O).  
The accurate mass measurements showed that the loss of 117 Da corresponds to C4H7NO3 
(Figure 3.4). Further analysis suggests that the neutral loss consists of an oxazolone ring and a 
water molecule (C4H5NO2 + H2O).  From Figure 3.5 D, the loss becomes 120 Da; here residue A
i 
contains the CD3 side chain, thereby establishing that the oxazolone ring containig A
i is lost. This 
suggests that it is structure [AAAWα-MeAoxa + H]
+ that dissociates. The corresponding loss from 
[AWα-MeA
15NACD3Aoxa + H]
+ is 118 Da (Figure 3.7 A) and this is consistent with losing the 15N-
alanine residue in position Ai; when residues Aiii and Aiv contain the heavy isotopes (Figure 3.7 
B), then the loss is only 117 Da, again consistent with the Ai residue being lost. 
The spectra for the 18O-labeled structures in Figure 3.6 provide the most definitive 
evidence for the structure of the ion that dissociates to give the m/z 368 ion.  Substitution of the 
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oxygen atoms in either residue Ai or Aiv results in losses of 119 Da, implicating involvement of 
both residues. The removal of the oxazolone ring from the C-terminus of structure [AAAWα-MeAoxa 
+ H]+ (formally creating an [a4]
+ ion, product not observed) via the cleavage of Cα−C bond is 
assisted by the steric crowding at the α-carbon of the α-methyltryptophan residue. This is 
immediately followed by the loss of water from residue Aiv.  A similar mechanism in which the 
Cα−C bond exocyclic to an oxazolone ring is cleaved has recently been proposed by Bythell and 
Harrison to explain the formation of [a1]
+ ions directly from [b2]
+ ions.77   
 
Ion at m/z 441, the loss of CO2.  
The loss of CO2 is one of the more interesting features of the [b5]
+ ion in this study.  To 
determine the mechanism for such a dissociation, residues Ai and Aiv were labeled separately with 
18O in the sequence [AAAWα-MeAoxa + H]
+ (Figures 3.6). When residue Ai was labeled with 18O, 
the product ion after the loss of CO2 retained the label (m/z 443), indicating that residue A
i is not 
involved. Since the loss of CO2 is mostly likely from the oxazolone ring, where there are two 
oxygen atoms bonded to a carbon, the loss of CO2 in this system cannot come from ion [AAAWα-
MeAoxa + H]
+, where residue Ai is part of the oxazolone ring.  Conversely, when the 18O label was 
on residue Aiv, the label was lost in the CO2 (m/z 441), indicating that one of the oxygen atoms in 
the CO2 comes from the amide oxygen of residue A
iv This implies that the [b5]
+ ion macrocyclizes 
and re-opens into either sequence [AAAAWα-Me oxa + H]
+ or [Wα-MeAAAAoxa + H]
+.  As 
[AAAAAoxa + H]
+ does not dissociate by loss of CO2, it seems probable that it is the [AAAAWα-
Me oxa  +H]
+ structure that undergoes this loss.  
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3.1.4 Energy-resolved plot for dissociation of [b5]+ ion [AAAAWα-Me oxa + H]+ 
 
The energy-resolved curves in Figure 3.8 establish that the lowest energy dissociation 
pathway for [AAAAWα-Me oxa + H]
+ is loss of CO to form the [a5]
+ ion.  At a slightly higher 
collision energy the combination of the [a1]
+ ion (m/z 173) and the [b4′]+ ion (m/z 285) is generated;  
 
Figure 3.8 Energy-resolved breakdown diagram for [AAAAWα-Me oxa + H]
+ ion. 
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these are the complementary products of cleaving the amide bond of A−Wα-Me of an [a5]+ ion in 
which the α-methyltryptophan  residue is at the C-terminus.  The abundance of the [a1]+ ion 
continues to increase at higher collision energies, indicating that this ion has a very stable structure.  
In contrast, the abundance of the [b4']
+ ion plateaus at intermediate collision energies showing it 
to be slightly less robust.  At higher collision energies, where there are many products, the sum of 
the abundances of [a1]
+ and [b4']
+ ions is substantially higher than those of all other ions, with the 
exception of the m/z 441 ion which, on the basis of 18O-labeling, we have deduced is also probably 
produced from isomer [AAAAWα-Me oxa + H]
+.  Increasing the collision energy a little more results 
in formation of the complementary [b2]
+ and [b3']
+ ions (m/z 272 and 214 respectively), essentially 
at the same onset. As labeling established that the [b3']
+ ion always contains residues Ai, Aii, and, 
Aiii, this complementary pair are the products of cleaving a peptide bond in either [AAAAWα-Me 
oxa + H]
+ or [AWα-MeAAAoxa  +H]
+.  The [b4]
+ ion is another potential source of the [b3']
+ ion. 
However, the abundance of the [b2]
+ ion, the fragment that carries the α-methyltryptophan residue, 
is always approximately double that of the [b3']
+ ion, suggesting that the [b2]
+ and [b3']
+ ions are 
formed in the same dissociation process. 
 Loss of only one alanine residue to create the [b4]
+ ion at m/z 414 has a similar onset to 
formation of the [b2]
+/[b3']
+ combination.  The labeling experiments showed that residues Ai and 
Aiv are each lost about 40% of the times, Aii is lost 20% and Aiii is never lost.  Assuming that these 
residues are lost from an oxazolone ring via a [a5]
+ ion, then this indicates the participation of three 
different isomers and that there has been some sequence scrambling of the initial [b5]
+ ion.  Only 
the sequence [AW-MeAAAoxa + H]
+, where residue Aiii is at the C-terminus, is not implicated.    
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The channel for loss of water creating a [b5 − H2O]+ ion at m/z 467 has a similar onset to those for 
formations of [b4]
+,  [b2]
+ and [b3']
+ ions. From the labeling experiments (Figure 3.6), this water 
is not lost from residues Ai and Aiv.    
Dissociation to [b3]
+ (m/z 343), involving loss of two alanine residues, has a slightly higher 
energy threshold than for losses of only one alanine or of three alanine residues.  Labeling 
established that residue Aii is always lost and that Ai and Aiii are lost in approximately the same 
amounts. This implies that more than one isomer of [b5]
+ undergoes cleavage of a peptide bond.  
Only the isomer in which residue Aii is in the central location, [W-MeAAAAoxa + H]
+, can be ruled 
out as a potential precursor .  
As the [b4']
+ curve flattens out at higher collision energies the [a4']
+ (m/z 257) appears and 
almost simultaneously the [b3']
+ (m/z 214) starts to grow. Loss of CO2 (generating the ion at m/z 
441), the channel that is dominant at the highest collision energies, has a higher onset energy than 
all the preceding channels.  This ion subsequently loses trialanine amide, AAANH2, to form an 
ion at m/z 211 that is very heavily stabilized by spreading the charge onto the indole ring (Figure 
3.9). 
The ions with the highest initial energy onsets are products at m/z 396 and 368.  The former 
is very minor and is the [b4 – H2O]+. The latter is the result of losses of the oxazolone ring and 
water and is most easily explained as originating from the rearranged structure, [AAAWα-MeAoxa + 
H]+. The energy-resolved curves for [AAAWα-MeAoxa + H]
+, given in Figure 3.10, show some 
differences from those in Figure 3.8; this appears to be the result of incomplete scrambling.  The 
product ions in both sets of curves and the onsets are the same but the abundances differ.  Most 
notably, the m/z 368 ion is more abundant in Figure 3.10 and, as isotopic substitution led us to 
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Figure 3.9 CID spectrum of ion at m/z 441, after loss of CO2 from the [b5]
+ ion.   
 
conclude that this product comes from the [AAAWα-MeAoxa + H]
+ ion, it appears that there is 
incomplete scrambling prior to dissociation.  Here, we note that our theoretical studies give the 
barrier to formation of the macrocyclic ion, the proposed intermediate in the isomerization, is the 
largest for isomer [AAAWα-MeAoxa + H]
+ (Scheme 3.1).   
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Figure 3.10 Energy-resolved breakdown diagram for [AAAWα-MeAoxa + H]
+ ion. 
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Scheme 3.1  Interconversion of the [b5]
+ ions via cyclization into a common cyclic pentapeptide. 
The enthalpies (ΔHo0 ) and free energies (ΔGo298 in parenthesis), both in kcal mol-1, are relative to  
[AAAAWα-Me oxa  +H]
+, structure  IV. 
 
Another more minor difference in the two sets of breakdown curves is that the ratio [b3]
+ / 
[b2]
+, which is essentially 1 in the curves for [AAAAWα-Me oxa + H]
+, is now closer to 2 for 
[AAAWα-MeAoxa + H]
+.  Recalling that the isotopic labeling established that the A−Wα-Me amide 
bond is never broken in formation of both [b3]
+ and [b2]
+ ions, then having more of the product 
which does not necessitate prior rearrangement, the [b3]
+ ion, again is consistent with a larger 
amount of dissociation from [AAAWα-MeAoxa + H]
+.  Finally, the abundance of [a5]
+ ion (m/z 457) 
is slightly higher from [AAAWα-MeAoxa + H]
+ and this probably reflects that [a5]
+ ions having the 
remnants of an alanine residue at the C-terminus are more robust than the one that has the α-
methyltryptophan at that location.         
 
 
 
 53 
 
3.2 Theoretical investigations 
 
From the energy-resolved curves the lowest energy dissociation channel is for the loss of 
CO forming an [a5]
+ ion, followed by cleavage of the A−W-Me amide bond to create the [b4']+ / 
[a1]
+ combination of ions.  Formation of the latter products requires the intermediacy of an [a5]
+ 
ion derived from [AAAAWα-Me oxa + H]
+, i.e.  the -methyltryptophan residue is located at the C-
terminus (Figure 3.11). Here, DFT calculations are used to examine interconversion between  
 
Figure 3.11 The proposed structure of the [b5]+ ion used for DFT calculations after rearrangement. 
 
different [b5]
+ isomers via the macrocyclic structure along with possible dissociation pathways 
from the lowest energy isomer. Note that for computational simplicity we have opted to use four 
glycyl residues rather than the slightly larger alanyl residues that we examined experimentally, i.e. 
the theoretical study is for the dissociation channels of [G4W-Me oxa + H]
+.      
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3.2.1 Method of calculations 
 
Geometry optimizations and calculations of harmonic vibrational frequencies were 
performed using the Gaussian 09 suite of programs (Revision D.01)78 with the B3LYP functional 
based on Becke’s three-parameter exchange potential 79,80 and the Lee, Yang and Parr correlation 
functional.81 The standard Pople 6-31++G(d,p) basis set was used for all calculations.82,83 All 
structures were characterized by harmonic frequency calculations; intrinsic reaction coordinate 
calculations were used to determine the two minima associated with each transition state 
structure.84 Throughout the text the relative energies quoted are enthalpies at 0 K (ΔHo0 values). 
 
3.2.2 Isomers of [b5]+ 
 
Scheme 3.1 summarizes the relative energies of four different [b5]
+ ions, as well as the 
energy barriers for head-to-tail cyclization for each isomer.  Isomer [GGGGWα-Me oxa+H]
+, 
structure IV (Figure 3.11), has the lowest energy among all the [b5]
+ ions and the barriers to 
interconversion via a macrocyclic structure are in the range 20-28 kcal mol-1.  The macrocyclic 
ion has the highest energy and lies 19.6 kcal mol-1 above  IV. 
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3.2.3 Dissociation pathways 
 
The proposed mechanism for loss of CO is described in pathway A in Scheme 3.2. It has  
a barrier of 30.5 kcal mol-1 leading to an [a5]
+ ion.  This is slightly higher than the barriers to 
interconversion between isomers of the [b5]
+ ion.  Subsequent dissociation of the [a5]
+ ion has a 
higher energy (33.1 kcal mol-1) to produce an ion-molecule complex (VI)  which dissociates to 
give the [b4′]+ and [a1]+ ions; formation of the [a1]+ ions is the thermodynamically favored product. 
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Scheme 3.2 Proposed mechanism for the loss of CO, which further dissociates to become [a1]
+ 
ion of α-methyltryptophan and the [b4′]+ ion. 
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Scheme 3.3 Proposed mechanism for the loss of AAoxa from the N-terminus of the [b5]
+ ion. 
 
Scheme 3.3 describes cleavage of the second protonated amide bond producing the [b3]
+ 
ion and neutral AAoxa via a solvated complex.  Here the barrier to the formation of the solvated 
complex has the highest barrier, 39.7 kcal mol-1.  Similarly, cleavage of the third protonated 
peptide bond gives the [b2]
+ and [b3′]+ ions with the former favored with an endothermicity of 41.3 
kcal mol-1(Scheme 3.4).  Both products were observed experimentally with the [b2]
+ ion in higher 
abundance at all collision energies.  Note that Pathways B and C have similar endothermicities 
and were found to have similar onset energies (Figure 3.8). 
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Scheme 3.4 Proposed mechanism for the formation of the [b3′]+ and [b2]+ ions 
 
In the first step to the loss of CO2 (Scheme 3.5, Pathway D), a hydride from the β-carbon 
of the side chain of the α-methyltryptophan residue migrates to a carbon in the oxazolone ring, 
thereby formally transferring the charge onto the side chain (XIV). Cleavages of the C−C and 
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Scheme 3.5 Proposed mechanism for the loss of CO2. 
 
C−O bonds simultaneously in the oxazolone ring lead to the loss of CO2.  The barrier for this 
reaction is 44.2 kcal mol-1 for the hydride transfer and is slightly higher than the other pathways 
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for the dissociation of [GGGGWα-Me oxa + H]
+, consistent with the higher onset energy in the 
energy-resolved diagram (Figure 3.8).  
 The ion at m/z 368 is a result of the loss of an oxazolone ring containing residue Ai and a water 
molecule containing an oxygen from residue Aiv; these products are most easily rationalized as 
coming from [AAAWα-MeAoxa + H]
+. The mechanism for this dissociation using the analogous 
glycyl system, ion III (Figure 3.12), is summarized in Pathway E (Scheme 3.6). First, the Cα−C 
bond of the α-methyltryptophan residue breaks and forms a complex with an [a4]+ ion hydrogen 
bonded to the oxazolone (XVI). This cleavage is analogous to the dissociation of [b2]
+ ions into  
 
 
 
Figure 3.12 Structure of [GGGWα-MeGoxa]
+ used for calculation for the loss of an oxazolone ring 
and a water molecule. 
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Scheme 3.6 Proposed mechanism for the loss of an oxazolone ring and a water molecule. 
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[a1]
+ ions recently reported.52  In the highest energy step in Scheme 3.6 a β-proton from the side 
chain of the α-methyltryptophan residue is then transferred to the oxazolone, forming an ion-
molecule complex at much lower energy (17.7 kcal mol-1). Proton transfer from the protonated 
oxazolone followed by separation leads to the formation of structure XVIII. Nucleophilic attack 
by the indole on the carbon of the protonated amide, followed by two proton transfer steps leads 
to the loss of water. The final product, ion XXI, has an additional aromatic ring and the extra 
stabilization afforded by this results in the overall reaction being slightly exothermic. All the steps 
in the loss of water have lower energies than the second step in the loss of oxazolone (XVI→XVII, 
48.6 kcal-1); consequently, the losses of oxazolone and water are concomitant. 
 
 
3.3 Summary 
 
  Comparable fragmentation patterns were observed for a series of protonated hexapeptides, 
both with and without an α-methyl group on the tryptophan residue, with the formation of [b5]+ 
ions being the most abundant product for every peptide. This indicates that substituting a methyl 
group onto the -carbon of the tryptophan residue does not affect the dissociation mechanisms, 
despite the additional steric crowding introduced at the -carbon.  
The fragmentations of the two types of [b5]
+ ions are very different. The CID spectra of the 
[b5]
+ ions containing an -methyltryptophan residue are more complicated than those of [b5]+ with 
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a ‘normal’ tryptophan residue. Both series of [b5]+ ions undergo head-to-tail macrocyclizations 
prior to dissociation, as reflected by isomers having very similar CID spectra. Common to both 
classes of [b5]
+ ions are losses of CO (giving [a5]
+ ions), and a single amino acid residue (giving 
[b4]
+ ions).   
The energy-resolved curves for two sequences, ions [AAAWα-MeAoxa + H]
+ and 
[AAAAWα-Me oxa + H]
+ are similar, but not identical, indicating that scrambling is not complete. 
Loss of CO is the lowest energy dissociation pathway, with subsequent cleavage to form the imine 
derived from α-methyltryptophan, an internal [a1]+ ion along with the complementary [b4']+ 
occurring at slightly higher collision energies.  The formation of the latter implies that [AAAWα-
MeAoxa + H]
+ has rearranged to [AAAAWα-Me oxa + H]
+ prior to dissociation.     
The spectra of -methyltryptophan-containing ions have high abundances of the internal 
[a1]
+ ion, and in this respect differ from the spectra of the [b5]
+ ions containing ‘normal’ tryptophan 
(Figure S1), showing the stabilizing effect of the α-methyl group. At higher collision energies loss 
of CO2 becomes the dominant pathway and 
18O labeling showed that this involves residue Aiv and 
is most easily understood in terms of loss from [AAAAWα-Me oxa + H]
+.  Another higher energy 
dissociation pathway involves the loss of neutrals with a combined mass of 117 Da.  Labeling and 
accurate mass measurements established that the neutral products lost were water (from residue 
Aiv) and the oxazolone ring incorporating residue Ai.  These losses are concomitant and appear to 
come from ion [AAAWα-MeAoxa + H]
+.      
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CHAPTER 4: Fragmentation of 
Radical Peptide Cations of α-
methyltryptophan-containing 
Hexapeptides and Their [b5 – 
H]•+ Ions 
 
 
4.1 Results and discussions 
4.1.1 Fragmentation of the hexapeptide radical cations 
 
The CID spectra of hexapeptides containing an α-methyltryptophan residue are simpler 
than those of the corresponding peptides in which hetero-residue is a tryptophan, and the 
abundances of [b5 – H]•+ ions are low, except in the dissociation  of [AAAAWα-MeG]•+ (Figure 
4.1).85  For each hexapeptide radical cation, all the major products are the results of bond cleavages 
around the α-carbon of the α-methyltryptophan residue, a consequence of steric crowding.  For 
[AWα-MeAAAG]
•+ the [z5 – H] •+ ion is the major product and is a result of cleaving the N-Cα bond 
of the Wα-Me residue.  Similarly, [zm – H]•+ ions are in high abundance in the spectra of the other 
peptide radical cations. Note that in Figure 4.1 d), the CID spectrum of [AAAAWα-MeG]
•+, it is 
the complementary ion [c4 + 2H]
+ at m/z 302 that is the more abundant than the [z2 – H]•+ ion.   
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Figure 4.1 CID spectra of peptide radical cations from α-methyltryptophan-containing 
hexapeptides, with the hetero-residue at different positions of the peptide. 
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Cleavage of the Cα–Cβ bond of the side chain of the α-methyltryptophan residue as 3-
methyleneindolenine (loss of 129 Da) provides the base peak for [AAWα-MeAAG]
•+ and [AAAWα-
MeAG]
•+ and is present for the other two peptides. 
The spectrum of [AAAAWα-MeG]
•+ has one product, an [a5]
+ ion; and its dissociation 
product, a [b4]
+ ion.  This involves the homolytic cleavage of the Cα–C bond of the α-
methyltryptophan residue, formally losing the radical C•ONHCH2COOH. 
 
4.1.2 Fragmentation of [b5 – H]•+ ions 
 
The CID spectra of the four [b5 – H]•+ ions composed of one α-methyltryptophan residue and 
four alanine residues (Figure 4.2) are very different from each other, indicating that there is no 
sequence scrambling in this set of ions. This is in marked contrast with the spectra of the various 
[A4Woxa]
•+ ions, where there was complete scrambling and only the isomer with the tryptophan at 
the C-terminus dissociated.  Despite the differences in the spectra in Figure 4.2 there are some 
observable patterns: 
- All spectra show the corresponding [b4 – H]•+ ion.  The loss of the alanine residue (71 Da) 
occurs from three of the ions and the α-methyltryptophan residue is lost from [AAAAWα-
Me oxa]
•+.  The spectra of the isotopically labeled [b5 – H]•+ in Figure 4.3 establishes that for 
[AAAWα-MeAoxa]
•+ the alanine residue at the C-terminus is the one that is lost.  These data 
are consistent with the [b5 – H]•+ ions having unrearranged oxazolone structures. 
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Figure 4.2 CID spectra of the [A4Wα-Me oxa]
•+ ions, with the α-methyltryptophan located at different 
positions. 
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Figure 4.3 CID of [AAAWα-MeAoxa]
•+ ions, a), b), c) with CD3 labels and d), e) with 
18O labels, at 
different alanine residues. 
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- Loss of the side chain as a radical (130 Da) occurs from the first three ions in Figure 4.2, 
but not from [AAAAWα-Me oxa]
•+, where the α-methyltryptophan residue would be in the 
oxazolone ring and loss of the side chain would create an improbable structure in which 
there are two double bonds attached to the nitrogen.  Loss of the side chain is most easily 
rationalized as being homolytic cleavage of the Cα–Cβ of the π-radical cation isomer. Such 
loss was not observed from [b5 – H]•+ ions that contain a tryptophan residue without the α-
methyl group. 
- Three of the spectra have a product ion at m/z 343, corresponding to the loss of dialanine 
radical (141 Da), forming [b3]
+ ion. The exception is in the spectrum of [AWα-MeAAAoxa]
•+, 
where there is only one alanine residue at the N-terminus.  Isotopic labeling (Figure 4.3) 
established unambiguously that it is the two residues from the N-terminus of [AAAWα-
MeAoxa]
•+ that are lost. The N-terminal captodative structure is a likely precursor to this 
channel. 
 
- Three of the spectra show losses of (AmNH2-2H), an imine-amide structure, 
HN=C(CH3)(CONHC(CH3))(m-1)CONH2, where m is 1 in 4.2 b), 2 in 4.2 c), and 3 in 4.2 
d). These products are the result of cleavage of the N–Cα bond of the alanine residue on 
the N-side of the α-methyltryptophan residue.  Isotopic labeling in Figure 4.3, where m is 
2, establish that it is the first two residues of [AAAWα-MeAoxa]
•+ that are lost.  The 
unsaturation at the N-terminus of the imine-amide is most easily rationalized in terms of 
loss from the N-terminal captodative structure. 
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- Losses of CO and CO2 occur but the products are in very low abundances. Similar behavior 
was noted for the [b5 – H]•+ ions derived from tryptophan-containing hexapeptides.59 By 
contrast, the closed-shell [b5]
+ ions containing an α-methyltryptophan lose both CO and 
CO2 in high abundance, with the CO loss occurring at lower onset energies than the loss of 
CO2.  
 
There are some features of the spectra that are unique to individual isomers. These include: 
- A loss of 116 Da from [AAAWα-MeAoxa]•+.  One possibility here was that this might be the 
loss of an indole radical as has previously been observed in the dissociation of peptide 
radical cations containing a tryptophan residue,2 but isotopic labeling (Figure 4.3) showed 
that both the carbonyl oxygens in alanine residues adjacent to the α-methyltryptophan 
residue are lost. This corresponds to a loss of an oxazolone radical, (C4H4O2N)
• plus H2O.  
A loss of 117 Da was observed in the fragmentations of the analogous [b5]
+ ions and these 
were attributed to dissociation of [AAAWAoxa+H]
+ ions (Scheme 3.6). 
 
- In the spectrum of [AAAWα-MeAoxa]•+ there is a minor product at m/z 211 and this is present 
in all the spectra in Figure 4.3, showing that none of the heavy isotopes in these different 
isotopomers is retained.  One of the most abundant products in the CID of [AAAWα-
MeAoxa]
•+ is the ion at m/z 327 and a subsequent CID of this ion gave only the ion at m/z 
211, again a loss of 116 Da.  
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- Isomer [AWα-MeAAAoxa]•+ is the only ion that showed a simultaneous loss of three alanine 
residues (217 Da), creating the [b2 – H]•+, the dominant product.  Formation of this ion 
would be facilitated by cleaving the second amide bond of the N-terminal captodative 
radical.  This [b2 – H] •+ ion would be heavily stabilized by the captodative effect as it has 
a powerful electron donor (the NH2 group) and a strongly electron-withdrawing group, the 
protonated oxazolone.  
 
4.1.3 Energy-resolved plot for dissociation of the ion [AAAWα-MeAD3oxa]•+  
 
The energy-resolved breakdown diagram generated for the ion [AAAWα-MeA
D3
oxa]
•+ 
indicated that the loss of the side chain as a radical (130 Da) and the loss of dialanine radical (141 
Da) are the most easily formed fragment ions, and the loss of the side chain radical dominates at 
higher energy (Figure 4.4). The next lowest barrier is for the loss of the imine-amide, which is the 
loss of (AANH2 – 2H) from this ion. We should note that this ion reaches its maximum abundance 
at mid-range collision energies, then begins to decrease in abundance at higher energies. In contrast 
to this ion, the ion at m/z 211, which is a further loss of 116 Da after the loss of imine-amide, 
increases rapidly at high energies. This is a good indication that the ion at m/z 211 is a dissociation 
product from the ion after the loss of the imine-amide. 
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Figure 4.4 Energy-resolved breakdown diagram for dissociation of the ion [AAAWα-MeA
D3
oxa]
•r+. 
“-130 Da” refers to a loss of the tryptophan side chain as a radical. 
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4.2 Proposed dissociation pathways 
4.2.1 Isomers of the [AAAWα-MeAoxa]•+ ion 
 
The CID spectra in Figure 4.2 clearly show that there is no isomerization between the four 
isomeric [b5 – H]•+ ions.  Our most extensive isotopic labeling studies have been on isomer 
[AAAWα-MeAoxa]
•+ and for this reason we have limited our computational work to this isomer. 
In previous study on the [b5 – H]•+ ions derived from tryptophan-containing hexapeptides, 
the ions macrocyclize and are able to rearrange into different isomers. DFT calculations found that 
the isomer [AAAAWoxa]
•+ with the radical located at the α-carbon of the tryptophan residue is at 
the global minimum of all isomers. In this study, the same α-carbon is blocked by a methyl group, 
which inhibited the event of sequence scrambling by requiring an alternative location for the 
radical. Our best interests was to investigate the new location of the radical, and investigate how 
it prevents sequence scrambling of the ion. 
Based on DFT calculations, the best structure for the [b5 – H]•+ ions has the radical center 
located at the α-carbon of the N-terminal residue  (Figure 4.5 (I)), compared to the structure with 
a β-radical  (Figure 4.5 (II)) or the canonical structure  (Figure 4.5 (III)). The radical in this 
structure is stabilized by the electron-donating nitrogen and the electron-withdrawing protonated 
oxygen next to it. Such a captodative structure delocalizes the charge at the N-terminus, making 
the N-terminus less nucleophilic. At the same time, the oxazolone at the C-terminus is less 
electrophilic without the charge. Hence, forming the captodative structure for the [b5 – H]•+ ion 
prevents macrocyclization and inhibits sequence scrambling. 
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Figure 4.5. Possible structures for the [A4Wα-Me oxa]
•+ ions, with relative energies. The enthalpies 
(ΔHo0 ) and free energies (ΔGo298 in parenthesis), both in kcal mol-1, are relative to  structure I. 
 
4.2.2 Loss of one residue from C-terminus 
 
 As described previously, the losses of one residue from the [b5 – H]•+ ions are observed to 
come from the C-terminus of the original sequence without scrambling. It would be logical to 
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suggest that the mechanism for such loss follows the conventional mechanisms for gas-phase 
protonated peptide fragmentation, by first losing a CO from the oxazolone ring at the C-terminus 
which gives the [a5 – H]•+ ion, followed by the further loss of the amine. Such mechanism is shown 
in Scheme 4.1 as pathway A. 
 
 
Scheme 4.1 Proposed mechanism for the loss of one residue from the C-terminus for the [A4Wα-
Me]
•+ ions. 
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4.2.3 Loss of oxazolone with a radical and water 
 
The [b5 – H]•+ ion showed a loss of 116 Da only when the α-methyltryptophan is at the 
fourth position, which corresponds to a loss of the oxazolone ring with a radical and a water 
molecule. This is analogous to the loss of 117 Da from the [b5]
+ ions containing α-
methyltryptophan. Thus, we propose similar mechanism for the loss of 106 Da from the ion 
[AAAWα-MeAoxa]
•+, which is described as pathway B in Figure 4.2. Starting from the captodative 
structure (I), HAT from the β-carbon of the α-methyltryptophan side chain changes the radical 
center to be a β-radical. Then, a homolytic cleavage of the Cα-C bond between the α-
methyltryptophan residue and the oxazolone ring results in a loss of the oxazolone ring with a 
radical (98 Da), contrasts to the closed-shell structure (99 Da) being lost from the [b5]
+ ion in its 
loss of 117 Da. A six-membered ring is formed via nucleophilic attack by the indole ring to the 
closest carbonyl carbon, where the carbonyl oxygen is protonated. After proton transfer, a water 
molecule is quickly lost, and a conjugated three-ring system is formed. The final product is the 
same ion at m/z 368 that has been observed in CID of the closed-shell [A4Wα-Me oxa + H]
+ ions after 
a loss of 117 Da. 
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Scheme 4.2  Proposed mechanism for the loss of 116 Da, which is a loss of the oxazolone ring 
radical and a water molecule, from [AAAWAoxa]
•+ ion. 
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4.2.4 Loss of side chain as a radical 
 
The side chain loss from the CID of the [b5 – H]•+ ions is the loss of an open-shell fragment 
with the radical (130 Da), contrasts to the loss of a closed-shell fragment (129 Da) from CID of 
the peptide radical cation. Proposed mechanism for this loss is described in pathway C (Scheme 
4.3).  The [b5 – H]•+ first migrates both the charge and the radical to the indole ring. Then, the Cα-
Cβ bond is cleaved, and the side chain with the radical is lost. This produces the ion at m/z 354 
with a protonated imine on the backbone. 
 
Scheme 4.3 Proposed mechanism for the loss of the side chain radical from the [A4Wα-Me oxa]
•+ 
ions.  
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4.2.5 Loss of dialanine oxazolone with a radical 
 
Isotopically-labeled [AAAWα-MeAoxa]
•+ ions clearly indicated that the loss of dialanine with 
a radical (141 Da) is from the N-terminus, and forms the most dominant peak in the spectrum. This 
is also one of the reasons that led us to believe that the radical center of the [b5 – H]•+ ion before 
dissociation is located at the N-terminus. The proposed pathway D begins with the captodative 
structure (I) (Scheme 4.4). Then, a cleavage of the second amide bond initially creates two 
oxazolone structures in a solvated complex. Next, a proton transfer to the C-terminal fragment 
occurs due to the higher proton affinity of the α-methyltryptophan residue, followed by 
dissociation of the complex. The final product shown in the spectra would be a [b3]
+ ion from the 
C-terminus of the original sequence, which corresponds to a loss of dialanine radical from the N-
terminus.  
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Scheme 4.4 Proposed mechanism for the loss of dialanine radical from the N-terminus of the 
[A4Wα-Me]
•+ ions. 
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4.2.6 Loss of imine-amides 
 
Loss of an imine-amide by cleavage of the N-Cα bond of the residue at the N-side of the α-
methyltryptophan residue is another pattern in the CID of the [A4Wα-Me oxa]
•+ ions. Such 
dissociation pattern is novel in CID of b-type ions, which implies that the α-methyltryptophan 
residue may play a role in the dissociation mechanism. A proposed mechanism for the loss of 
imine-amides is described in Scheme 4.5 as pathway E. Structure (I) first forms a solvated 
complex of two fragments, after a homolytic cleavage of the N-Cα bond of the residue at the N-
side of the α-methyltryptophan residue. This initially forms a charged fragment from the N-
terminus, and the C-terminal fragment with a radical located at the α-carbon of the alanine residue 
on the N-terminus of the α-methyltryptophan residue. Next, in the C-terminal fragment, a HAT 
occurs from the β-carbon of the α-methyltryptophan residue to the α-carbon of the alanine residue 
at the N-terminus, migrating the radical center to the β-carbon. This is followed by a proton transfer 
from the N-terminal fragment to the C-terminal fragment, and produces the ion at m/z 327 shown 
in the CID spectra.  
The next part is a further loss of 116 Da from the ion at m/z 327, which follows the 
mechanism described previously. Homolytic cleavage of the Cα-C bond results in the loss of the 
oxazolone ring with the radical (98 Da). This is immediately followed by a six-membered ring 
formation and a loss of a water molecule. The resulting product is a stable three-ring structure at 
m/z 211. 
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Scheme 4.5 Proposed mechanism for the loss of imine-amides from the N-terminus of the 
[A4Wα-Me]
•+ ions, followed by a further loss of 116 Da. 
 
i) 1,6 P.T. 
ii) N-Cα cleavage 
1,7 P.T. 
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4.3 Summary 
We have learned that the fragmentation of α-methyltryptophan-containing hexapeptides 
results from cleavages of the bonds around the α-carbon of the α-methyltryptophan residue, due to 
steric crowding. As a result, these peptide radical cations mainly produces a series of [zm – H]•+ 
ions, and a loss of the 129 Da closed-shell fragment of the tryptophan side chain. The [b5 – H]•+ 
ions generated in the CID spectra of these peptide radical cations are in very low abundance. 
The marked difference for the dissociation of the [b5 – H]•+ ions derived from α-
methyltryptophan-containing peptides is that there is no sequence scrambling. This means that 
CID of the [b5 – H]•+ ions with the hetero-residue at different positions produce non-identical 
spectra, and fragment ions shown in these spectra have characteristic information from the original 
sequence, as indicated from isotopically-labeled peptides. For example, loss of one residue is 
unambiguously from the C-terminus of the original sequence. Energy-resolved breakdown curve 
of the ion suggested that loss of dialanine radical and loss of the tryptophan side chain radical have 
the lowest energy barriers. It also indicated that the after the [AAAWα-MeAoxa ]
•+ ion loses an imine-
amide from the N-terminus, it can further lose 116 Da, which is the loss oxazolone ring as a radical 
and a water molecule.  
The loss of 116 Da is also present in the CID spectra of the [b5 – H]•+, but only form the 
sequence [AAAWα-MeAoxa]
•+. This is analogous to the loss of 117 Da from the analogous closed-
shell [b5]
+ ions. The fact that the loss of 116 Da is only present in CID of the sequence [AAAWα-
MeAoxa]
•+ further supported that the proposed mechanism for the loss of 117 Da from the analogous 
closed-shell [b5]
+ ions begins with the ion [AAAWα-MeAoxa + H]
+ after sequence scrambling.  
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CHAPTER 5: Fragmentations of  
[b5 – H]•+ Ions Containing 
Tyrosine or Methionine Residues 
 
 
5.1 Dissociation of [b5 – H]•+ radical cations 
 
In the ongoing study of sequence scrambling in [b5 – H]•+ ions, we have learned that ions 
derived from tryptophan-containing hexapeptides ([A4Woxa]
•+) demonstrate complete sequence 
scrambling, with one resulting sequence ([AAAAWoxa]
•+) that dissociates (Figure 3.3).59 The ion 
[AAAAWoxa]
•+ is proposed to have the radical center located at the α-carbon of the tryptophan 
residue in the oxazolone ring, which induces fragmentations. In this thesis, we have explored the 
[b5 – H]•+ ion in the same way, but with a methyl group located at the α-carbon of the tryptophan 
residue. Here, we noticed the opposite behavior. The CID spectra of isomers of [A4Wα-Me oxa]
•+ are 
non-identical, and clearly showed no evidence of rearrangements from the fragments based on 
isotopic labeling experiments. This is due to the captodative radical located at the N-terminus of 
the ion, which reduces the nucleophilicity of the N-terminal nitrogen and prevents the ion from 
undergoing head-to-tail macrocyclization. The [A4Woxa]
•+ and [A4Wα-Me oxa]
•+ ions provided 
consistent results that explain when and why [b5 – H]•+ ions scramble.  
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On the other hand, there is a previous study on the [A4Goxa]
•+ ions, generated by cleavage 
of the side chain from [A5W]
•+ ions followed by further CID, which initially generated a radical at 
the α-carbon of the glycine residue (Figure 5.1).51 However, this system did not follow either one 
of the trends mentioned above, and showed both evidences for isomerization and for no 
isomerization, based on CID of the different sequences and isotopically-labeled peptides. In 
addition, we further studied the [A4Yoxa]
•+ and [A4Moxa]
•+ ions to further explore [b5 – H]•+ ions in  
 
Figure 5.1 CID spectra of the [A4Goxa]
•+ ions, with the glycine residue at different positions. 
Figure adapted from Lau et. al.51 
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different systems, looking for  similarities between the different systems. The [A4Yoxa]
•+ ions were 
generated by CID of the hexapeptide radical cations, which was generated as described in earlier 
studies (Figure 5.2).85 We note that the [A4Moxa]
•+ ions were generated directly from CID of 
[hexapeptide + Cu(II) + (18-crown-6)]•2+ complex instead of from the hexapeptide radical cation 
[A4MG]
•+, due  to the absence of the peptide radical cation in the CID of the complex shown in 
Figure 5.3. Also note that for additional confirmation of the [b5 – H]•+ ion, the peptide used in 
Figure 5.3 d) has a methylated alanine residue at the C-terminus, in contrast to the glycine residue 
for other peptides used in Figure 5.3 a), b), and c), while the [b5 – H]•+ ion with the same m/z 415 
was still observed and isolated. 
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Figure 5.2 CID spectra of tyrosine-containing hexapeptides. Figure adapted from Mädler et. al. 85 
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Figure 5.3 CID spectra of the [pep + Cu(II) + L]•+ complexes, where “L” refers to the ligand used, 
18 crown 6; and hexapeptides refers to “pep” refers to hexapeptides with the methionine residue 
at varying positions. 
 
CID spectra of [A4Yoxa]
•+ ions are given in Figure 5.4. In contrast to the CID of the closed-
shell [b5]
+ ions of [A4Yoxa]
+, which exhibited complete scrambling, the [b5 – H]•+ radical cations 
showed similarities across different sequences, but are non-identical.54 The spectra consist of the  
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Figure 5.4 CID spectra of the [A4Yoxa]
•+ ions, with the tyrosine residue at different positions. 
“107 Da” corresponds to the radical structure of the tyrosine side chain. 
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same fragment ions across different sequences, but relative abundances of certain ions differ 
drastically between different sequences. For example, the [b2 – H]•+ ion resulting from a loss of 
three alanine residues at m/z 234 is at around 60% relative abundance in the CID of [AYAAAoxa]
•+ 
ion, while the same ion in the CID spectrum of [AAYAAoxa]
•+ or [AAAYAoxa]
•+ ion is at less than 
1% abundance. The [b4′ – H]•+ ion resulting from a loss of the tyrosine residue (m/z 284) is present 
in all spectra, but at different abundances, which suggests that some rearrangement occurred before 
dissociation.  
The loss of CO2 (m/z 403) is a dominant peak in most of the spectra. This observation is 
consistent with CO2 loss in the spectra of the [A4Goxa]
•+ ions; it differs from the spectra of both the 
[A4Woxa]
•+ ions and [A4Wα-Me oxa]
•+ ions, where CO2 loss  is always in negligible abundance. In 
addition to the dominant loss of CO2, other fragments include the loss of one, two, and three alanine 
residues, which becomes the [b4 – H]•+ (m/z 376) , [b3 – H]•+ (m/z 305), and [b2 – H]•+ ions (m/z 
234). A [b3]
+ ion from a loss of dialanine radical (m/z 306) is also present in all spectra, with the 
complementary [b2′ – H]•+ ion (m/z 142). There is a loss of 107 Da in all spectra (m/z 340), which 
corresponds to the loss of the tyrosine side chain radical. The complementary ion of the [b2 – H]•+ 
ion, which is the [b3′]+ ion from losing one tyrosine and one alanine residue with the radical (m/z 
214) is also present at low abundance in some of the spectra. 
CID spectra of [A4Moxa]
•+ ions are summarized in Figure 5.5. The CID of these ions also 
have the same fragment ions across different sequences, but again the relative abundances of the 
fragment ions are different, making the spectra non-identical. As the  [A4Yoxa]
•+ ions, loss of CO2 
in the CID of [A4Moxa]
•+ ions is also the dominant peak in all spectra. Losses of alanine residues, 
which form the series of [bn – H]•+ ions (n = 4,3 and 2) are also present. Analogous to the [A4Yoxa]•+ 
ions, the complementary pair of [b2′ – H]•+ (m/z 142) and [b3]+ ions (m/z 274) are present in the  
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Figure 5.5 CID spectra of the [A4Moxa]
•+ ions, with the methionine residue at different positions. 
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CID of the [A4Moxa]
•+ ions. Also, the corresponding [b4′ – H]•+ ion (m/z 284) and [b3′ – H]•+ ion 
(m/z 213) are also present at small abundance. The [A4Moxa]
•+ ions showed a loss of a closed-
shell side chain fragment of 74 Da (m/z 341), H3SCH=CH2. In addition, [AMAAAoxa]
•+ and 
[AAMAAoxa]
•+ also lose CH3SCH3 (giving an ion at m/z 353), while [AAAMAoxa]
•+ and 
[AAAAMoxa]
•+ showed a loss of •CH2SCH3 (giving an ion at m/z 354).There is also a loss of 
HSCH3 (giving an ion at m/z 367) from all sequences. 
 
 
5.2 Information provided by isotopic labeling and breakdown diagram 
5.2.1 CID of 18O-labeled [AAAYAoxa]•+ ions 
 
The sequence AAAYAG was chosen to put 18O label on all four different positions of 
alanine residues, and the CID spectra of the labeled [AAAYAoxa]
•+ ions, m/z 449,  are summarized 
in Figure 5.6. The most notable observation here is the loss of CO2. In all four spectra, the CO2 
lost consists of a mixture of the labeled and the unlabeled oxygen. When the label is on the first, 
second, or third residue, loss of CO2 without the label is the dominant peak, followed by a minor 
loss of the labeled 18O=C=O (~10% relative abundance) (Figure 5.6 a), b), and c)). When the 
label is on the fifth residue, the opposite is true, with the loss of 18O=C=O being the dominant 
(Figure 5.6 d)). This suggests that there are some rearrangements of the [b5 – H]•+ ions, and there 
is more than one structure that dissociates to give the CID spectra, at least for the loss of CO2. 
However, the majority of fragment ions originate from the original sequence. 
The m/z of the [b4 – H]•+ ions showed loss of an unlabeled alanine residue had occurred when the 
label is on the first, second, or third residue. When the label is on the fifth residue, the loss is a  
 93 
 
 
Figure 5.6 CID spectra of [AAAYAoxa]
•+ with 18O label on different positions. 
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mixture of both the labeled and the unlabeled alanine, in approximately the same abundance 
(Figure 5.5 d)). This suggests that at least half of the [b4 – H]•+ ions is from the original sequence. 
The [b3 – H]•+ ion does not retain the label when the label is on the first or second residue, and 
retains the label when it is on the third or fifth residue. However, a minor mixture of the opposite 
(~10% relative abundance) is present in the spectra of [A18OAAYAoxa]
•+ and [AA18OAYAoxa]
•+. 
We can conclude that the majority of the two alanine residues being lost here are the first and 
second alanine residues from the N-terminus; with also a minor loss of the second and the third 
residues. The [b2 – H]•+ ion only retained the label when it is on the fifth residue; as well, the 
complementary [b3′]+ ion has lost the label only when the fifth residue is labeled. The spectra of 
the [b2′ – H]•+ ions showed that the label is retained when it is on the first or second residue from 
the N-terminus. Since the relative abundance of these two fragment ions are both very low (< 5%), 
any minor mixture of these ions would be in negligible abundance. 
The fragment ions after the dominant loss of CO2 from [AAAYAoxa]
•+ were further selected 
for CID, and the spectra were given in Figure 5.7. The ion can further lose two or three alanine 
residues, as well as the side chain, but the most dominant fragment from this ion is the loss of 
dialanine amide. Based on the spectra, when the first or second residue was labeled, the label was 
lost with the loss of dialanine amide (m/z 244). The ion selected from [AAAYA18Ooxa]
•+ has lost 
the label from the initial loss of CO2 (Figure 5.7 d)). Only the fragment ion from [AAA
18OYAoxa 
– CO2]•+ retained the label (m/z 246) after the loss of dialanine amide (Figure 5.7 c)).  This 
indicates that, after the loss of CO2 from [AAAYAoxa]
•+, it further loses dialanine amide from the 
N-terminus, by cleavage of the N-Cα bond between the second and the third residue.  
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Figure 5.7 CID spectra of [AAAYAoxa – CO2]•+, with 18O label on different positions. Note that 
the parent ion selected for d) has already lost the 18O label from the initial CO2 loss. 
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5.2.2 CID of CD3- and 15N-labeled [AAAMAoxa]•+ ions 
 
CD3 and 
15N labels were both put on the sequence AAAMAG. Two peptides were 
synthesized, with the CD3 and 
15N label on different positions as described in Figure 5.8, which 
covered all four alanine residues. Based on the spectra in Figure 5.8, it can be concluded that the 
loss of one alanine residue is from the C-terminus, and the loss of two alanine residues is from the 
N-terminus, from the original sequence of the [AAAMAoxa]
•+ ion. There are also minor evidences 
indicating loss of one or two alanine residues from the sequence [AAMAAoxa]
•+: a minor peak for 
loss of an 15N-labeled alanine residue exists in CID of [A15NAD3AMAoxa]
•+ ion (Figure 5.8 b)); 
and there is also a minor peak for the loss of dialanine oxazolone with the 15NN label from CID of 
[AAAN15MAD3oxa]
•+ ion (Figure 5.8 c)). The complementary pair of the [b2′ – H]•+ ion and the 
[b3]
+ ion are unambiguously the results of a cleavage between the second and third residue from 
the N-terminus of [AAAMAoxa]
•+. The loss of three alanine residues ([b2 – H]•+ ion) and the loss 
of a methionine residue and an alanine residue ([b3′ – H]•+ ion) both showed a mixture of peaks 
and are at very small abundance, thus cannot be used to draw conclusions. 
The ions after loss of CO2 from the two labeled [AAAMAoxa]
•+ ions have also been isolated 
for further fragmentation, and the CID spectra are given in Figure 5.9. CID of these ions revealed 
that the most dominant fragment is the loss of •CH2SCH3 from the side chain (m/z 314). The only 
significant difference between the CID spectra of the two ions with labels on different positions 
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Figure 5.8 CID spectra of [AAAMAoxa]
•+, and the same sequence with CD3 and 
15N label on 
different positions. “-74 Da” refers to loss of the closed-shell side chain fragment (CH2CHSCH3). 
Note that in c) the loss of CD3-labeled alanine residue is isobaric with the loss of CH2CHSCH3. 
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Figure 5.9 CID spectra of the ion [AAAMAoxa – CO2]•+ from the labeled peptides. 
 
is the ion at m/z 169 from [A15NAD3AMAoxa – CO2]•+, versus the ion at m/z 171 from 
[AAA15NMAD3oxa – CO2]•+. This species was generated from dissociation of the most abundant ion 
in the spectrum, [A4Moxa – CO2 – •CH2SCH3]+ (m/z 314), as illustrated by further isolation and 
CID of the ion (Figure 5.10). The former can be translated to a loss of two alanine residues with 
one CD3 label (145 Da) from [A4Moxa – CO2 – •CH2SCH3]+, while the latter is a loss of two alanine 
residues with one 15N label (143 Da). From here, we can conclude that after the loss of CO2 from 
[A4Moxa]
•+, the ion most easily dissociates by losing •CH2SCH3 from the side chain, and then 
further lose two alanine residues from the second and the third residue. The proposed mechanism  
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Figure 5.10 CID of the ion [AAAMAoxa – CO2 - •CH2SCH3]+ from the labeled peptides. 
 
for this pathway is that  loss of CO2 from the [b5 – H]•+ ion is followed by a HAT, to generate a 
structure with the radical center at the N-terminal α-carbon (Scheme 5.1). This radical then attacks 
the beta-carbon of the methionine, which forms a macrocyclic structure and displaces the 
•CH2SCH3 fragment from the side chain via homolytic cleavage. This macrocyclic structure then 
re-opens at the N-terminal of the methionine residue, which exposes the two alanine residues that 
were originally in the middle of the ion [AAAMAoxa]
•+ to the C-terminus. Finally, a stable six-
member ring structure is formed by nucleophilic attack by the nitrogen atom from the N-terminus, 
and the two alanine residues that are now at the C-terminus are lost.  
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Scheme 5.1 Proposed mechanism for dissociation pathway after loss of CO2 from [A4Moxa]
•+. 
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5.2.3 Energy-resolved diagram of ion [A15NAD3AMAoxa]•+  
 
An energy-resolved breakdown diagram of the ion [A15NAD3AMAoxa]
•+ was generated and 
shown in Figure 5.11. The curve indicates that the loss of CO2 has the lowest energy barrier, and 
is the most dominant fragment at all collision energies. At higher collision energies, the relative 
abundance for the loss of CO2 begins to drop, and other fragments that require higher energy starts 
to increase.  
The next most abundant fragment ions are the [b4 – H]•+ ion and the [b2′ – H]•+ ion, which 
share similar abundance across all energies. However, the complementary ion for the [b2′ – H]•+ 
ion, which is the [b3]
+ ion, lies below as the next most abundant ion. This indicates that the AAoxa
• 
fragment must have a slightly higher proton affinity than the AMAoxa fragment. The [b3 – H]•+ ion 
has a relatively high onset energy compared to other fragment ions, but quickly increases in 
abundance at higher collision energy. From this particular breakdown diagram, the energy barrier 
for the loss of two alanine residues that produces the [b3 – H]•+ ion is greater than that for the loss 
of one alanine residue, at all energies. 
Below the [b3]
+ ion, next most abundant ion, especially at lower collision energies, is the 
loss of the closed-shell side chain fragment, CH2CHSCH3 (74 Da). At higher energies, the 
fragment from a loss of CH2CHSCH3 plus NH3 (91 Da) starts to increase rapidly. This possibly 
suggests that the mechanism leading to the loss of CH2CHSCH3 will lead to a further loss of an 
NH3 at higher energy.  
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Figure 5.11 Energy-resolved breakdown diagram of the ion [A15NAD3AMAoxa]
•+;the CID spectrum 
is given in Figure 5.6 (b). 
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5.3 Discussions 
 
Based on the CID spectra of [A4Yoxa]
•+ and [A4Moxa]
•+ ions, we noticed similarities in the 
two different series of [b5 – H]•+ ions. These similarities can also be linked to the CID spectra of 
[A4Goxa]
•+ ions that have been studied.  In all of the three series, CID spectra produced from the 
[b5 – H]•+ ion with the hetero-residue at different position are non-identical, with the same fragment 
ions but at different relative abundance. Labeling experiments have been done for each series. 
They all suggested that there is some of rearrangement, and that there is more than one structure 
undergoing dissociation when producing the CID spectra. This behavior is different from the 
[A4Woxa]
•+ ions that fully rearranged into one common sequence before dissociation, and the 
[A4Wα-Me oxa]
•+ ions that exhibit no rearrangements and dissociate from the original structure. Here 
we summarize the similarities and differences between the CID of [A4Yoxa]
•+, [A4Moxa]
•+, and 
[A4Goxa]
•+, to conclude some general dissociation patterns in [b5 – H]•+ ions. 
 
5.3.1 The most dominant peak: loss of CO2 
 
 In all of the [A4Yoxa]
•+, [A4Moxa]
•+, and [A4Goxa]
•+ ions, the most dominant fragment ion 
from the CID of the [b5 – H]•+ ion is frequently the loss of CO2. This is the major characteristic 
shared between the three series. It is also a marked difference that distinguishes these three series 
from the [A4Woxa]
•+ ions or the [A4Wα-Me oxa]
•+ ions, where loss of CO2 is negligible. From the 
study of the [A4Goxa]
•+ ions, we have learned that the loss of CO2 is facilitated by an α-radical 
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located next to the oxazolone ring (Scheme 5.2). We have also learned that for the ions 
[AG•AAAoxa]
+, [AAG•AAoxa]
+, and [AAAG•Aoxa]
+, the energy barrier to macrocyclization is lower 
than the barrier for HAT and subsequent loss of CO2, while ion [AAAAG
•
oxa]
+ is the most easily 
formed ion from ring-opening of the macrocyclic structure (Scheme 5.3). A subsequent 1-13 HAT 
in this ion, followed by formation of a second macrocyclic structure and ring-opening, results in 
the ion [AAGA•Aoxa]
+, which has the lowest barrier for CO2 loss of all isomers. 
 Since CO2 loss is also the most dominant peak in the CID spectra of [A4Yoxa]
•+and 
[A4Moxa]
•+ ions, and they share similarities in fragmentation patterns, we may suggest similar 
dissociation mechanisms for the loss of CO2 in these ions. Based on the 
18O-labeled [AAAYAoxa]
•+, 
CO2 loss is from more than one structure, but majority of the ion is from a CO2 loss from the ion 
[AAAYA18Ooxa]
•+. It is reasonable to propose that the radical center in this ion is at the α-carbon 
of the tyrosine residue, which is next to the oxazolone ring, and is sufficiently stabilized by the 
tyrosine side chain. This may facilitate CO2 loss, with mechanisms similar to that for the [A4Goxa]
•+ 
ions. Whether the [A4Yoxa]
•+ ions rearrange and isomerize into the ion [AAAY•Aoxa]
+ before CO2 
loss or such loss occurs from the original structure is unclear, as the ion [AAAYAoxa]
•+ is the only 
sequence selected for 18O-labeling and no theoretical calculations have yet been done. For the 
[A4Moxa]
•+ ions, although CO2 loss is also the most dominant peak in all CID spectra, no 
18O-
labeling work has been done to reveal information about the loss of CO2. 
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Scheme 5.2 Mechanism for loss of CO2 from AAAG
•Aoxa
+. The enthalpies (ΔHo0) and free 
energies (ΔGo298, in parentheses) in kJ mol-1 are relative to isomer AAAG•Aoxa+ and were 
calculated at the B3LYP/6-31++G(d,p) level (regular fonts). Single-point energies at the M06-
2X/6-311++G(d,p) level (in italic fonts) were calculated on selected systems for comparisons. 
Figure adapted from Lau et. al.2 
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Scheme 5.3 Isomerization of [A4Goxa]
•+ ions via macrocyclization and HAT, to produce structures 
with radical center at the α-carbon next to the oxazolone ring, followed by the loss of CO2. The 
enthalpies (ΔHo0) and free energies (ΔGo298, in parentheses) in kJ mol-1 are relative to isomer 
AAAG•Aoxa
+ and were calculated at the B3LYP/6-31++G(d,p) level (regular fonts). Single-point 
energies at the M06-2X/6-311++G(d,p) level (in italic fonts) were calculated on selected systems 
for comparisons. Figure adapted from Lau et. al.2 
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5.3.2 Cleavage of the second amide bond: [b2′ – H]•+ and [b3]+ 
 
 Another dissociation pattern that is common in all of the [A4Yoxa]
•+, [A4Moxa]
•+, and 
[A4Goxa]
•+ ions is the cleavage of the second amide bond to give the complementary pair of [b2′ – 
H]•+ ion and [b3]
+ ion, although both ions appear in low relative abundance. All isotopic-labelling 
experiments done for these peptides indicated that they are the ions formed by second amide bond 
cleavage from the sequence [AAAXAoxa]
•+ (X = G, Y, or M). This implies that formation of the 
[b2′ – H]•+ ion and [b3]+ ion from other sequences must have rearrangement of the [b5 – H]•+ ion 
before dissociation.  
 Formation of the [b3]
+ ion by loss of a dialanine radical is also present in the CID of the 
[A4Wα-Me oxa]
•+ ions, with the difference that these ions do not isomerize, and such a loss is absent 
in the sequence [AWα-MeAAAoxa]
•+ because it cannot occur without rearrangement. Here, we can 
suggest a similar mechanism for the cleavage of the second amide bond (Scheme 5.4). Starting 
with a captodative structure of the [b5 – H]•+ ion with the radical at the N-terminal α-carbon, proton 
transfer to the second amide nitrogen followed by nucleophilic attack by the N-terminal oxygen, 
results in cleavage of the second amide bond. Initially, a solvated complex is formed; this consists 
of the [b2′ – H]•+ of the two alanine residues from the N-terminus, and another oxazolone structure, 
the [b3]
+ ion, with the remaining three residues from the C-terminus. These two species will 
compete for proton affinity within the complex. Eventually, the complex dissociates, and both ions 
have sufficiently similar proton affinities to acquire the proton and be detected.  
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Scheme 5.4 Proposed mechanism for cleavage of the second amide bond from the N-terminus, for 
CID of (I) [A4Goxa]
•+ (II) [A4Yoxa]
•+, and (III) [A4Moxa]
•+ ions. 
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5.3.3 Loss of alanine residues 
 
 In the CID spectra of all three series of [b5 – H]•+ ions ([A4Yoxa]•+, [A4Moxa]•+, and 
[A4Goxa]
•+ ions), [b4 – H]•+, [b3 – H]•+, and [b2 – H]•+ ions are present, the product of the loss of 
one, two, or three alanine residue, respectively. Loss of one residue from a closed-shell b-type ion 
is usually achieved by an initial loss of CO, giving an a-type ion, followed by the loss of the 
remainder of the residue. Based on the isotopic-labeling experiment, loss of one alanine residue in 
all three series consists of a mixture, indicating that the [b4 – H]•+ ion is formed from the 
dissociation of more than one isomer.  
Loss of two alanine residues is mostly from the N-terminus of the sequence [AAAXAoxa]
•+ 
(X = G, Y, or M), with also a minor mixture. This is supported by isotopic-labeling of 
[AAAXAoxa]
•+ for all three series (Figure 5.6 and Figure 5.8).51  
Loss of three alanine residues as an oxazolone, is in very low abundance from isomer  
[AAAXAoxa]
•+ in all three series, and for X = tyrosine, the loss is definitely from the N-terminus 
(Figure 5.6). The loss of three alanine residues from  [AYAAAoxa]
•+ and [AMAAAoxa]
•+, forming 
the [b2 – H]•+ ion, is one of the major pathways (60% - 100% relative abundance), compared to the 
very minor product when the hetero-residue is at other positions. 18O-labeled [AG•AAAoxa]
+ 
revealed that the [b2 – H]•+ ion (m/z 128) is from the loss of three alanine residues from the C-
terminus of the original sequence (Figure 5.12).  
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Figure 5.12 CID spectra of [AG•AAAoxa]
+, with 18O label at different positions. “*” indicates the 
18O label. Figure adapted from Lau et. al.2 
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5.3.4 Loss of the hetero-residue 
 
In both the [A4Yoxa]
•+ and [A4Moxa]
•+ ions, there is a corresponding [b4′ – H], ion at m/z 284 
via loss of the hetero-residue (Y or M) in all sequence, although the relative abundance varies and 
is present at very low abundance in some spectra (Figure 5.3 and Figure 5.4). This species is not 
observed in the [A4Goxa]
•+, [A4Woxa]
•+, or the [A4Wα-Me oxa]
•+ ions. Loss of the hetero-residue is a 
sign of sequence scrambling.  
 
5.3.5 Loss of the side chain 
 
In the study of α-methyltryptophan-containing hexapeptides, we observed the loss of side 
chain fragments. CID of the hexapeptide radical cations showed losses of 129 Da, which is a 
closed-shell fragment; in contrast, the [b5 – H]•+ ions showed losses of 130 Da, corresponding to 
an open-shell radical fragment (Figure 5.13 a)). CID of the [A4Yoxa]
•+ ions also showed a loss of 
the open-shell radical side chain (107 Da) in all sequences, although the relative abundance varies 
(Figure 5.13 b)). However, we cannot conclude that all [b5 – H]•+ ions lose the radical side chain, 
since the [A4Moxa]
•+ ions showed losses of the closed-shell side chain fragment (74 Da) (Figure 
5.12 c)). The fact that the [A4Moxa]
•+ ions can also lose parts of the side chain (HSCH3, CH3SCH3, 
and •CH2SCH3) and that the ion after loss of 74 Da tends to further lose an NH3 indicates that the 
[A4Moxa]
•+ ions may undergo unique pathways for the loss of side chain fragments. 
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Figure 5.13 Structures and corresponding molecular weights of both the closed-shell and open-
shell side chain fragments for a) tryptophan, b) tyrosine, and c) methionine. 
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5.4 Summary 
 
We have studied the fragmentation behavior of [A4Yoxa]
•+ and [A4Moxa]
•+ ions and found 
similar behaviors between the dissociation of [A4Yoxa]
•+, [A4Moxa]
•+ and [A4Goxa]
•+ ions. For all 
three series, CID of the [b5 – H]•+ ions with the hetero-residue at different positions showed non-
identical spectra; the fragment ions are identical but there are different relative abundances, and 
there is evidence for rearrangement of the [b5 – H]•+ ions before dissociation. Key characteristics 
for the dissociation of the [b5 – H]•+ ions from these three series have been summarized. The most 
dominant peak in all the spectra from these three series is always the loss of CO2, which is found 
to have the lowest onset energy based on the energy-resolved breakdown diagram of 
[A1NAD3AMAoxa]
•+. Spectra of isotopically-labeled [AAAXAoxa]
•+ ions indicated that majority of 
the fragment ions are from the original sequence. However, it remains unclear whether these 
dissociation pathways apply on the original structure of each sequence, or if the [b5 – H]•+ ions 
macrocyclize and the sequence [AAAXAoxa]
•+ is the most preferred structure for ring-opening and 
dissociation. Further isotopic-labelling experiment with the tyrosine or methionine residue on 
other positions is required. 
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CHAPTER 6: Summary and 
Future Works 
 
In this thesis, we have answered the question to whether the α-methyl substituent on the 
tryptophan residue affects fragmentation patterns of protonated peptides, peptide radical cations, 
closed-shell [b5]
+ ions, and open-shell [b5 – H]•+ ions. For dissociation of protonated peptides, 
having the methyl group on the α-carbon of the tryptophan does not affect the dissociation. 
Protonated peptide ions with or without the α-methyl group both produce the [b5]+ ion as the most 
dominant fragment. For dissociation of the peptide radical cations, however, ions with a normal 
tryptophan residue predominantly produce [b5 – H]•+ ions, while ions with the α-methyl substituent 
tend to dissociate by cleavages around the α-carbon due to steric crowding. This produces mainly 
the [zm – H]•+ ions and the ion after the loss of 3-methyleneindolenine, with very little [b5 – H]•+ 
ions produced.  
 Fragmentation of the [b5]
+ ions with the α-methyltryptophan residue is also very different 
from those with a normal tryptophan residue, despite the fact that both showed sequence 
scrambling. Dissociations of [A4Wα-Me oxa + H]
+ ions produce high abundance of the [a5]
+ ion, as 
well as the complementary pair of internal [a1]
+ ion and [b4′]+ ion by cleavage between the four 
alanine residues and the α-methyltryptophan residue from the [a5]+ ion of [AAAAWα-Me oxa + H]+. 
The [b5]
+ ions with the α-methyltryptophan residue also lose CO2, and this becomes the dominant 
pathway at higher collision energies. With sufficient collision energy, these [b5]
+ ions also lose a 
fragment of 117 Da, which corresponds to a combined loss of a neutral fragment of the oxazolone 
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ring and a water molecule that are from alanine residues on both sides of the α-methyltryptophan 
residue from the ion [AAAWα-MeAoxa + H]
+.  
 For the [b5 – H]•+ ions with the α-methyl substituent on the tryptophan residue clearly 
showed that, by preventing the formation of the α-radical on the tryptophan residue proposed for 
[b5 – H]•+ ions with normal tryptophan residues, the best structure for the [b5 – H]•+ ion would have 
a captodative radical at the N-terminal α-carbon. This reduces the nucleophilicity of the N-terminal 
nitrogen, and prevents head-to-tail cyclization and sequence scrambling. One marked observation 
is that a loss of 116 Da, which appears to be a combined loss of the oxazolone with a radical and 
a water, is only observed in the dissociation of [AAAWα-MeAoxa]
•+, consistent with the observation 
that no isomerization occurs in this set of ions. This provided a further support for the proposed 
dissociation mechanism for the analogous loss of 117 Da from the ion [AAAWα-MeAoxa + H]
+. 
 Studies done for the [A4Yoxa]
• + and [A4Moxa]
•+ systems indicated that they shared 
similarities in fragmentation patterns with the [A4Goxa]
•+ system and may be grouped together. 
These three systems all showed indications of rearrangement before dissociation, but relative 
abundance of the fragment ions differ significantly between spectra with the hetero-residue at 
different positions. Isotopic-labelling experiments done for each system all implies that the 
fragment ions are mixtures of products from more than one structure, while the majority is from 
the original sequence [AAAXAoxa]
•+ (X = G, Y, or M) that was selected for isotopic-labelling.  
 Although the experiments were well-designed, and reliable data were obtained and 
analyzed, there are some potential limitations in this work that need to be addressed. First, since 
no calculation work has yet been done for any of the work related to the open-shell ions except for 
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the structure of the [A4Wα-Me oxa]
•+ ions, all of the dissociation mechanisms drawn for these ions 
are simply proposed mechanisms. These hypotheses are based on general gas-phase chemistry, 
without knowing the actual energy barriers and energies of the intermediate products. Secondly, 
most of the labeling works in the open-shell studies were done on peptides with the linear sequence 
where the hetero-residue is on the fourth position ([AAAXAoxa]
•+). This sequence was chosen 
because it generally produces richer fragmentation, including some unique features such as the 
loss of 116 Da from the [AAAWα-MeA oxa]
•+ ion, compared to other sequences. However, since the 
[b5 – H]•+ ions that we studied showed either no scrambling or incomplete scrambling, it is not 
enough to generalize dissociation patterns for all sequences by studying one particular sequence, 
especially without calculation supports. All of these potential pitfalls may lead to future directions 
for this work, which will include labeling on sequences where the hetero-residue is not at the fourth 
position; and DFT calculations on the intermediate structures and energy barriers of all proposed 
dissociation pathways. 
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